Conventional Water Treatment Processes for Removing Pharmaceutical and  Endocrine Disrupting Compounds by Lin, Jing
University of Massachusetts Amherst
ScholarWorks@UMass Amherst
Environmental & Water Resources Engineering
Masters Projects Civil and Environmental Engineering
5-2011
Conventional Water Treatment Processes for
Removing Pharmaceutical and Endocrine
Disrupting Compounds
Jing Lin
Follow this and additional works at: https://scholarworks.umass.edu/cee_ewre
Part of the Environmental Engineering Commons
This Article is brought to you for free and open access by the Civil and Environmental Engineering at ScholarWorks@UMass Amherst. It has been
accepted for inclusion in Environmental & Water Resources Engineering Masters Projects by an authorized administrator of ScholarWorks@UMass
Amherst. For more information, please contact scholarworks@library.umass.edu.
Lin, Jing, "Conventional Water Treatment Processes for Removing Pharmaceutical and Endocrine Disrupting Compounds" (2011).
Environmental & Water Resources Engineering Masters Projects. 46.
https://doi.org/10.7275/0Q3M-TE82
 
 
 
  
 
CONVENTIONAL WATER TREATMENT PROCESSES FOR 
REMOVING PHARMACEUTICAL AND ENDOCRINE 
DISRUPTING COMPOUNDS 
 
 
 
 
 
 
A Master’s Project  
Presented by  
Jing Lin  
 
 
 
 
Submitted to the Graduate School of 
 the University of Massachusetts in partial fulfillment  
of the requirements for the degree of  
 
 
 
 
 
MASTER OF SCIENCE  
 
In 
  
ENVIRONMENTAL ENGINEERING  
 
 
 
 
 
 
 
May 2011  
Department of Civil and Environmental Engineering  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
© Copyright by Jing Lin 2011  
All Rights Reserved 

iv 
 
ACKNOWLEDGEMENTS 
Work for this master’s project was funded by Water Research Foundation to establish 
guidelines of using ozone/GAC to remove endocrine disruptors in water.    
            I would like to thank Dr. David A Reckhow for giving me opportunities to study and 
work at the University of Massachusetts Amherst. Thank Dr. Reckhow for his valuable time 
and his willingness to offer expertise, for guidance and patience throughout this study. I 
would also like to thank the faculty of the environmental engineering graduate program for 
their academic help throughout my master’s study. I also want to express my gratitude to 
Sherrie Webb-Yagodzinski, Boning Liu, Kirsten Studer, Amada Keyes, Calvin Archibald, 
Amber Boles, Minh Pham and so many others for their help in the lab. I’d also like to thank 
Larry Karmer for helping analyze the LC/MS dataset. Thank you to Jodi Ozdarski for all the 
arrangements for my defense. I also owe thanks to my family members and friends who have 
always been there to give me generous support. 
 
 
v 
 
ABSTRACT 
CONVENTIONAL WATER TREATMENT PROCESSES FOR REMOVING 
PHARMACEUTICAL AND ENDOCRINE DISRUPTING COMPOUNDS 
May 2011 
JING LIN, B.S., HARBIN INSTITUTE OF TECHNOLOGY 
M.S., UNIVERSITY OF MASSACHUSETTS AMHERST 
Directed by: Professor David A. Reckhow 
 
Endocrine disrupting chemicals (EDCs) are natural or synthetic compounds that act 
like hormones in the endocrine system and disrupt the physiologic function 
of endogenous hormones.  Although no standards concerning EDCs in drinking water have 
been established, there are rising concerns about the effects of EDCs in drinking water on 
human health. 
The main objective of this study is to conduct bench scale experiments to investigate 
the effectiveness of conventional drinking water treatment processes at removing selected 
endocrine disrupting compounds (EDCs), pharmaceutical and personal care products (PPCPs) 
from municipal water supplies. It was also a goal of this work to provide utilities with 
information on likely removal of these compounds under a board range of water qualities and 
treatment scenarios. 
Raw water used for this work came from 15 participating utilities, and each utility 
had at least one source water and treatment system. Samples were collected at different times 
of the year, and important water quality parameters, such as UV254, TOC and DOC were 
vi 
 
measured. The concentration of the target compounds in the raw water, travel blank, and 
treated water was also measured. 
Overall, the treatment processes that include oxidation such as ozonation, chlorination 
and chloramination are the most effective processes resulting in around 80% to 100% of the 
target compounds removal. Chlorination alone is very effective at removing most of the 
target compounds that were studied. N-N-diethyltoluamide (DEET) and Tris (2 chloroethyl) 
phosphate (TCEP) are relatively resistant to all the treatment techniques that were tested 
(coagulation, ozonation, chlorination, chloramination and GAC/dual-media filtration). 
However, filtration on adsorptive media was able to remove most of the DEET when the 
DEET concentration was low. This could be due to the result of adsorption on the GAC 
media. The ozone-GAC biofiltration process is very effective at controlling and removing 
most target compounds.  
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CHAPTER 1 INTRODUCTION 
1.1 Background 
1.1.1 Endocrine Disrupting Chemicals 
Endocrine disrupting chemicals (EDCs) are exogenous substances, either natural or 
synthetic, that act like hormones in the endocrine system and disrupt the physiologic function 
of endogenous hormones.  
EDCs in water bodies were first discovered as natural estrogens in wastewater treatment 
plant effluent in the United States in 1965 (Zollinger et al., 1965). The first known report that 
specifically discussed the discharge of pharmaceuticals from a wastewater treatment plant 
was published by researchers from the University of Kansas in 1977 (Hignite, Azarnoff, 
1977). 
The most common sources for EDCs are the compounds that are naturally produced by 
plants and animals. Some pesticides and detergents that are hormonally active can also be 
EDCs. One study has found that EDCs can leach out of plastic (Canada Health, 2009). Some 
industrial products and their byproducts could contain EDCs. There are two major methods 
of classifications for EDCs: EDCs could be classified by structure which includes, but are not 
limited to steroid estrogens (e.g., estrone (E1), 17β-estradiol (E2), and estriol (E3)), synthetic 
estrogens (e.g., 17R-ethynyl estradiol (EE2)), and anthropogenic EDCs (e.g., nonylphenol 
(NP) and bisphenol A (BPA)) (Zhang et al., 2008); EDCs could also be classified by their 
effects on different hormones and there are generally three groups under this classification: 
estrogenic (compounds which mimic or block natural estrone); androgenic (compounds 
which mimic or block natural testosterone); thyroidal (compounds with direct or indirect 
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impact to thyroid gland) (Snyder et al., 2007). However, there is not a defined list of EDCs 
and future study is needed to determine whether a specific compound could have an adverse 
effect on the endocrine system (Snyder et al., 2007).  
EDCs and pharmaceutical and personal care products (PPCPs) received little concern 
when they were first discovered due to low concentration and the inability of the instruments 
at that time to detect organics at ng/L level until the late 1990s.  At that point, new analytical 
instruments had lowered the detection limits and  the presence of these compounds in water 
bodies were linked to the reproduction failure of fish in United Kingdom and United States.   
In a study with medaka (Oryzias latipes), the pesticide triphenyltin (TPT) was found to 
have significant adverse effects on spawning frequency, spawned egg number, egg quality 
and gonad development and induced teratogenesis with a TPT residual of 6.52 +/- 0.56 to 
5595 +/- 1016 ng of TPT/g of wet weight which is similar to those reported in wild fish 
around the world (Zhang et al., 2008).  
Although no studies have effectively linked low concentrations of EDCs in water to 
adverse health effects in humans, humans are exposed to EDCs in many sources.  Exposure 
can occur via soil, air, water, sediment, food and customer products. Semi-volatile substances, 
which include the majority of known EDCs, may be more or less strongly bound to 
particulate matter in the air, thus affecting possible absorption into the bloodstream and 
uptake via the gastrointestinal tract. Other EDCs in air may be deposited in terrestrial 
systems on leaves, needles, grass, soil (Jones et al., 1994) and in aquatic systems, where they 
enter the food chain (Stapleton et al., 2001). Several potential EDCs have been detected in 
the soil in different parts of the world (Lega et al., 1997; Hale et al., 2001; Kocan et al., 2001; 
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Stevens et al., 2001). Farm animals could be exposed to the contaminated soil through gazing 
and then contribute to human exposure through food chain pathway. Particular kinds of 
EDCs have been reported in sediments. Human exposure to this source is low and restricted 
to consumption of bottom feeding organisms (Damstra et al., 2002). Food intake is the major 
source for human exposure to EDCs. Persistent organic pollutants always bio-accumulate in 
the fat of the species at the top levels of the food chain (Natural Resouces Defense Council). 
For example, various phytoestrogens were discovered in a vegetable oil in 1951 (Levin et al., 
1951). Some over-the-counter medicine contains high concentrations of phytoestrogens. 
Phytoestrogens in human diet are reported to have an adverse effect on the human endocrine 
system (Shaw, McCully, 2002). Additional research is needed to examine the relationship 
between the phytoestrogens in human diet and human health. There is another example 
where people were exposed to high doses of EDCs.  This is the well-known case of DES, a 
strong synthetic estrogen that was given to pregnant women to prevent miscarriage during 
the 1930s to 1970s. The daughters of those women who took DES during pregnancy have 
been reported have higher rates of reproductive problems, reproductive cancer (vagina, 
cervix) and malformed reproductive organs (uterus, cervix) (Noller et al., 1983). DES sons 
have non-neoplastic changes and the likelihood of DES sons having epididymal cysts ranges 
from 21% to 30% compared to 5% to 8% of unexposed men (Gill, 1988). Multigenerational 
effects of DES were reported from a recent animal study (CDC, 2006). 
1.1.2 Pharmaceutical and Personal Care Products 
The category of pharmaceutical and personal care Products (PPCPs) refers to any 
products used by individuals for personal health and cosmetic reasons or products used by 
agribusiness to enhance growth or health of livestock. PPCPs comprise a diverse collection 
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of thousands of chemical substances, including prescription and over-the-counter therapeutic 
drugs, veterinary drugs, fragrances, and cosmetics.  
There are six major sources of PPCPs: human activity, illicit drugs, veterinary drug use 
(e.g. antibiotics, steroids), agribusiness, residuals from pharmaceutical manufacturing and 
residuals from hospitals. The impact of human activities on PPCPs in the environment has 
been largely overlooked. Although there are no reports that have linked the effects of PPCPs 
on human health and the risk of consuming water containing low levels of PPCPs is 
uncertain, public concern about PPCPs has been increasing.  It is widely recognized that 
modern wastewater treatment systems are not equipped for PPCP removal. With the 
increasing impacts of human activities, more PPCPs are finding their way into water bodies, 
especially those directly impacted by discharge of treated sewage.  
One of the first measurements of PPCPs at the ng/L level was reported by Heberer and 
Stan concerning clofibric acid in Berlin tap water (Heberer, Stan, 1997). 
1.1.3 Removal of EDCs and PPCPs 
Despite the fact that some EDCs and PPCPs can be partially removed by natural 
environmental attenuation such as adsorption and biodegradation, or they can be removed by 
conventional and advanced waste water treatment, complete removal of many of these 
compounds is impractical.  
Boyd and co-workers (Boyd et al., 2003) noted that Naproxen was not removed by 
conventional drinking water treatment in the full-scale Jefferson Parish plant (Louisiana). 
Several studies indicate that EDCs are little affected by conventional coagulation and 
flocculation except DEHP (C24H38O4), DBP (C16H22O4) and DEP (C12H14O4) that were 
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removed by 53%, 49%, and 46%, respectively (Choi et al., 2006). However, a recent study 
shows that a higher removal of steroid hormones could be achieved during coagulation by 
using a special aluminum coagulant (PAX-18) (Bodzek, Dudziak, 2006). Westerhoff and 
colleagues (Westerhoff et al., 2005) found almost no removal by alum or ferric coagulants of 
the various PPCPs in their laboratory study of spiked waters (28 compounds analyzed by 
LC/MS, including DEET, TCEP, estrone, sulfamethoxazole, naproxen, diclofenac, 
trimethoprim). Not included in their study were atorvastatin, atenolol, ranitidine and 
ciprofloxacin. Westerhoff and colleagues (Westerhoff et al., 2005) also noted that most 
PPCPs were removed by coagulation to a similar extent across the various water matrices 
that they studied. The one exception was a group of better removed hormones 
(androstenedione, progesterone, and testosterone). Here they speculated that the hormones 
became associated with particulate matter in some waters which increased their removal. 
Chemical oxidation as practiced in drinking water treatment, biological removal or 
transformation during wastewater treatment, and nanofiltration/reverse osmosis are the 
treatment techniques that are known to be most effective in removing EDCs and PPCPs 
(Benotti et al., 2010). 
Granular activated carbon (GAC) and powdered activated carbon (PAC) are highly 
effective in removing EDCs and PPCPs although its effectiveness can be diminished by the 
presence of natural organic matter (NOM).  NOM can compete for binding sites and can 
block pores within the activated carbon structure (Snyder et al., 2006). The removal 
efficiency of GAC and PAC for neutral organic compounds could be related to their octanol-
water partition coefficient (Kow). Adsorption through GAC is more effective with higher Kow. 
The removal efficiency of EDCs is not affected by GAC type and service time. But PAC is 
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not applicable in removing low concentrations of EDCs. While charged species exhibit a 
much more complex behavior and have much lower removals, the removal efficiency is 
largely dependent on pH and surface charge. The combination of GAC and ozonation is 
highly effective in removing most of the EDCs and controlling the concentration of oxidation 
by-products (Choi et al., 2006). One study showed that estriol removal efficiency by 
adsorption processes depended on the temperature and pH (Kumar et al., 2009). 
Ozone is an effective oxidant for EDC removal. Oxidation of EDCs and PPCPs depends 
on ozone dose and the structure of those compounds. The removal efficiency of these 
emerging contaminants is consistent with the magnitude of the reaction rate constant (Huber 
et al., 2003) and it is pH dependent as well as being dependent on temperature and organic 
carbon concentration (Zwiener et al., 2004). At higher pH (pH 7 and pH 11), more by-
products are formed and ozone could not achieve higher removal for all the estrogenicity 
while the residual concentration of 17β-estradiol is lower (Bila et al., 2007). However, ozone 
is not effective in removing all the target compounds. For instance, under certain testing 
conditions ozone achieves less than 40% removal of clofibric acid. With a residual 
concentration of 100 ng/L, ozone is less effective at the decomposition of nonylphenol 
(Zhang et al., 2008). Iodinated X-ray contrast media are also resistant to ozone. Moreover, 
atrazine, iopromide, meprobamate, and tris-chloroethylphosphate (TCEP) are resistant to 
ozone oxidation and are only removed by less than 50%. The addition of H2O2 for advanced 
oxidation adds little benefit to target compound removal as compared to ozone alone (Snyder 
et al., 2006).  
Chlorine is effective in removing a large number of EDCs and PPCPs through oxidation, 
substitution and addition reactions though it is not as strong an oxidant as ozone. Although 
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chlorination can reduce estrogenic activity it may also produce a large number of disinfection 
byproducts, e.g., trihalomethanes. Disinfection byproducts are considered to be a potential 
source for endocrine disruption. One study indicates that chlorination increases the 
antiestrogenic activity of the biologically treated waste water while it decreases the 
estrogenic activity of that water (Wu et al., 2009). Chlorine could rapidly react with EDCs 
that have a phenolic ring (Deborde et al., 2004; Lee et al., 2004). The reaction of aqueous 
chlorine with selected EDCs has a second order rate constant that depends on pH. The 
reaction rate constant is minimal at pH 5 and reaches a maximum between pH 8 and 10 
(Deborde et al., 2004). The removal of most of the PPCPs is also pH dependent: oxidation by 
free chlorine is more effective for removing naproxen at pH 5 and pH 7 than it is at pH 9 
(Boyd et al., 2005). While there are some excellent compilations of reaction rate constants 
for chlorine with many micropollutants, there is not the same level in information for 
chloramines. Accordingly, the data from Snyder and colleagues (Figure 1.1) are helpful to 
understand the relative effectiveness of combined versus free chlorine. 
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capable in removing in vivo estrogenic activity of the EDC mixture compared to single 
compounds (Chen et al., 2007). 
UV irradiation is not expected to oxidize organic compounds at low doses but a high 
dosage (i.e. >400mJ/cm2) may render UV light capable of oxidizing some organic 
compounds. When high energy UV irradiation is combined with H2O2, it is more effective in 
removing bisphenol A, ethynyl estradiol, estradiol and carbamazepine than UV alone. 
Photocatalytic degradation with TiO2 as the catalyst was shown to be efficient in 
removing most of the EDCs/PPCPs except PFOS, TCEP and tris (1-chloro-2-propyl) 
phosphate (TCPP). The removal followed pseudo-first-order kinetics as a function of the 
amount of treatment. No estrogenically active transformation products were formed during 
the treatment (Benotti et al., 2009). However, photocatalytic treatment has not yet been 
widely used in drinking water treatment. 
Membrane treatment is effective in removing a large number of micro pollutants without 
forming byproducts, but many studies have reported the rejection of micro-pollutants by 
nanofiltration (NF) membranes and reverse osmosis (RO) which depends on the target 
compounds, the type of the membrane, the feed water, the operational condition and the 
presence of NOM. NF membranes retain most EDCs and PPCPs via both hydrophobic 
adsorption and size exclusion while ultrafiltration (UF) membranes retain specific EDCs and 
PPCPs through hydrophobic adsorption. The retention of EDCs and PPCPs is affected by 
membrane pore size because the NF membrane achieves greater removal of the target 
compounds than the UF membrane. Furthermore, the retention is also affected by source 
water chemistry conditions (Yoon et al., 2006). Moreover, from another study, the UF as 
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well as the microfiltration (MF) was found to reject very few target compounds and only 
some loss of steroidal type compounds was observed especially when operated as membrane 
bio-reactor (MBR). Other studies show that NF membranes and RO could both achieve high 
removal for a group of negatively charged disinfection byproducts and pharmaceuticals while 
for neutral charged EDCs and PPCPs, RO had significantly better performance than NF 
(Adams et al., 2002; Drewes et al., 2002; Kimura et al., 2003; Xu et al., 2005). In addition, 
the tight NF membranes had higher rejection of hydrophobic compounds while RO provided 
effective removal of EDCs. A higher concentration of divalent ions reduced the rejection of 
membranes (Comerton et al., 2008). However, since only a limited number and type of target 
compounds have been studied and data supporting specific removal mechanisms are sparse, 
much more information is needed for the study of membrane removal effectiveness. 
Serrano and his co-worker have found that conventional activated sludge (CAS) system 
was able to completely remove acidic pharmaceuticals such as naproxen and ibuprofen. 
When including GAC in the CAS system, the absorption had significant effects on removing 
more recalcitrant compounds such as diazepam, carbamazepine (<= 40%) and diclofenac (<= 
85%) (Serrano et al., 2010). CAS removal of PPCPs depends on a lot of factors such as PPCP 
concentration, temperature, solids residual time (SRT) and hydraulic retention time (HRT) 
(Onesios et al., 2009). 
Oxidation processes, while generally effective, often lead to the formation and 
persistence of organic by-products with potentially undesirable properties.  Processes that 
rely on physical removal generally don't have this problem. In general, conventional 
treatment processes such as coagulation and flocculation are not able to remove most of the 
EDCs and PPCPs. GAC through adsorption is effective in controlling EDCs but the 
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effectiveness largely depends on the concentration of NOM in the water. Oxidation processes 
(e.g. chlorination, ozonation) have proved to be the most effective method to remove most of 
the EDCs, but results depend on the compound structure and the oxidant dosage. However, 
some of the compounds are resistant to oxidation. For example: atrazine, iopromide, 
meprobamate, tris-chloroethylphosphate (TCEP) and nonylphenol are strongly resistant to 
ozonation. Besides, some of the oxidation byproducts could be a potential source for 
endocrine disruption. Membrane treatment provides less by-products and it is one of the 
promising techniques for controlling EDCs and PPCPs in water, but more study is needed for 
reviewing their performance in water treatment. 
1.2 Research Objectives 
The following are the proposed objectives for this master’s project. 
1) To conduct bench scale experiments for the purpose of investigating the 
effectiveness of the conventional drinking water treatment processes at removing 
selected endocrine disrupting compounds (EDCs), and pharmaceutical and 
personal care products (PPCPs) from municipal water supplies. 
2) Provide participating utilities with information on likely removal of these 
compounds under a board range of water qualities and treatment scenarios. 
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CHAPTER 2 MATERIALS AND METHODS 
This chapter includes short descriptions of field sampling, bench scale testing, and 
analytical methods used in the research.  In many cases standard methods were employed and 
references have been made to detailed descriptions of those methods when generally 
available in the open literature. 
2.1 Field Sampling and Addition of Target Compounds 
There were 15 drinking water utilities that participated in this study, each with at least 
one source water and treatment system.  In all but one case, a single source or source blend 
was sampled for ambient and bench-scale testing.  In a few cases the sampling was repeated 
during the final year of the study.  In one case (#14), two separate sources were sampled.  
The specific sampling dates are listed in Table 2.1.  Note that each utility is identified only 
by a randomly-assigned number (1-16, excluding 6). 
Table 2.1:  Sampling Schedule 
Utility # Initial Re-sample 
14 11/20/2008
12 1/16/2009
13 2/3/2009
7 3/20/2009
10 4/13/2009 2/6/2010
16 4/13/2009
2 5/6/2009 12/18/2009
9 6/16/2009
8 4/6/2010
1 6/25/2009 4/17/2010
3 7/30/2009 2/25/2010
4 7/30/2009
5 3/23/2010
15 9/15/2009 4/10/2010
11 11/24/2009  
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All but two of the utilities were within driving distance of UMass and samples from 
the 13 nearby locations were collected by the principal investigator and driven back to the 
UMass labs within 24 hours.  All samples for analysis of ambient target compounds were 
collected in freshly-cleaned 2-L borosilicate glass bottles with PTFE-lined septum caps 
(Serum bottles with Red caps).  These were transported in a specially-constructed hard case 
with foam cushioning and spaces for ice-packs.  Large bulk samples for bench-scale testing 
were collected in 20-liter HDPE carboys.  Filter media from operating filters were collected 
in 1-liter wide mouth borosilicate bottles with PTFE-lined caps. 
All sampling vessels were acid washed and extensively rinsed with lab grade water 
prior to the sampling trip.  Once on site, they were rinsed with the sample at the time of 
collection.  Samples were all collected from existing raw water taps, usually free flowing at 
about 1-4 liters/minute.  Care was taken to assure that the sampling line was completely 
flushed prior to collecting the first sample.  One 2-liter bottle filled with lab-grade water was 
transported into the field and transferred to another 2-liter bottle at the time and location of 
sampling.  This was returned to the laboratory and analyzed with the other samples as the 
field blank.   
When possible, filter media from the full scale plant were collected at the same time 
as the raw water.  A 500 mL polyethylene beaker with an integrated 12 foot PE pole1 was 
used to collect media from the surface of a recently backwashed filter.  This was deposited 
into the wide-mouth bottle and rushed back to the UMass labs on ice. 
2.2 Spiking procedures 
All the target compounds were spiked into the sampled raw water at a concentration 
of about 500 nM (high level spike) and at a concentration of about 1 nM (low level spike) for 
                                                 
1 Fisher # 14-242-10. 
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each utility. The spiking solutions were prepared from a mixture of the individual primary 
aqueous stock solutions that have concentration ranges from 1 mg/L to 157 mg/L. 
2.3 Selected target compounds 
Table 2.2 summarizes the properties of the target compounds that were selected for 
this project. 
Table 2.2: Properties of selected target compounds 
Compound Formula Molecular mass (g/mol) 
Solubility 
(mg/mL) log Kow 
Atenolol C14H22N2O3  266.336 26.5 0.16
Atorvastatin C33H35FN2O5  558.64 1.23 3.5
Ciprofloxacin C17H18FN3O3  331.346 35 0.25-0.3
DEET C12H17NO 191.27 <1 2.02
Estrone C18H22O2 270.366 1.30E-03 3.13
Naproxen C14H14O3  230.259 5.11E-02 3.18
Sulfamethoxazole C10H11N3O3S  253.278 4.59E-01 0.9
Ranitidine C13H22N4O3S  314.4 7.95E-02 0.27
TCEP C9H15O6P 250.19 3.10E+02 1.78
Trimethoprim C14H18N4O3  290.32 <1 0.91
 
2.4 Target Compound Stock Solution 
12 selected target compounds were prepared in individual stock solutions using 
deionized water as the solvent. The stock solutions were stored in the dark at 4°C. The 
concentration of the stock solutions is summarized in Table 2.3. 
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Table 2.3: Concentration of the stock solution 
# Compound 
Amount of compound 
added to 1000 mL 
Water 
Volume of 
solution in mL 
Concentration in 
g/L 
1 
Estrone 0.0135 g 1000 0.0135
Ciprofloxacin 0.041g 1000 0.041
2 Naproxen 0.0113 g 1000 0.0113
3 TCEP 0.1 ml 1000 0.142
4 Sulfamethoxazole 0.127 g 1000 0.127
5 Ranitidine 0.157 g 1000 0.157
6 Atenolol 0.134 g 1000 0.134
7 DEET 0.024 ml 250 0.0958
8 Atorvastatin 0.029 g 1000 0.029
9 Trimethoprim 0.146 g 1000 0.146
10 NDMA 1.85 ml 1000 0.0372
11 Perchlorate (Na) 0.0285 g 1000 0.0285
12 Estrone alone 1 g 1000 1
 
2.5 Combined Spike Solution 
The high level spike solution (HL) and the low level spike solution (LL) were 
prepared from the target compound stock solution. The composition for the high level spike 
solution and the low level spike solution is listed in Table 2.4, Table 2.5, Table 2.6 and Table 
2.7. 
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Table 2.4:  Composition of the high level spike solution 
    
High Level spike 
soln 
# Compound 
mLs 
added 
to 
100 
mL 
total 
uM/L in 
HL spike 
soln 
1 
Estrone 
20
10.28
Ciprofloxacin 24.75
2 Naproxen 20 9.815
3 TCEP 4 19.90
4 Sulfamethoxazole 4 20.06
5 Ranitidine 4 19.95
6 Atenolol 4 20.14
7 DEET 4 80.13
8 Atorvastatin 28 13.99
9 Trimethoprim 4 20.12
10 NDMA 4 20.09
11 Perchlorate (Na) 4 9.311
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Table 2.5:  Final HL Concentration in Spiked Water 
    High Level spike soln 
# Compound 
mLs 
added 
to 
100 
mL 
total 
uM/L in 
HL spike 
soln 
Concentration 
in Sample 
(nM/L) 
Concentration 
in Sample 
(ng/L) 
1 
Estrone 
20
10.28 257.1 6630.7
Ciprofloxacin 24.75 618.7 63623.4
2 Naproxen 20 9.82 245.4 78620.2
3 TCEP 4 19.90 497.4 134647
4 Sulfamethoxazole 4 20.06 501.4 96272.8
5 Ranitidine 4 19.95 498.7 289262.2
6 Atenolol 4 20.14 503.5 145564
7 DEET 4 80.13 2003.3 148247.6
8 Atorvastatin 28 13.99 349.6 4982000
9 Trimethoprim 4 20.12 502.9 0
10 NDMA 4 20.09 502.2 0
11 Perchlorate (Na) 4 9.311 232.8 13261.7
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Table 2.6: Composition of the low level spike solution 
    Low Level spike soln 
# Compound 
mLs added to 100 
mL total 
uM/L in LL 
spike soln 
1
Estrone 
0.2
0.103 
Ciprofloxacin 0.247 
2 Naproxen 0.2 0.098 
3 TCEP 0.02 0.099 
4 Sulfamethoxazole 0.02 0.100 
5 Ranitidine 0.02 0.100 
6 Atenolol 0.02 0.101 
7 DEET 0.02 0.401 
8 Atorvastatin 0.2 0.100 
9 Trimethoprim 0.02 0.101 
10 NDMA 0.02 0.100 
11 Perchlorate (Na) 5 11.638 
12 Estrone alone 27 0.999 
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Table 2.7: Final LL Concentrations in Spiked Waters and Aqueous Standards 
Concentration Level 
(% of LL spiked water) 
→ 
Volumes Added (mL) 
0% 25% 50% 75% 100% 
Low Level SS 0 5 10 15 20 
DI or Raw Water 2000 2000 2000 2000 2000 
Concentration Level 
(% of LL spiked water) 
→ 
Concentration (nM) (ng/L) 
0% 25% 50% 75% 100% 100% 
Estrone 0.00 2.75 5.51 8.26 11.01       2,978  
Ciprofloxacin 0.00 0.62 1.24 1.86 2.47           820  
Naproxen 0.00 0.25 0.49 0.74 0.98           226  
TCEP 0.00 0.25 0.50 0.75 0.99           284  
Sulfamethoxazole 0.00 0.25 0.50 0.75 1.00           254  
Ranitidine 0.00 0.25 0.50 0.75 1.00           314  
Atenolol 0.00 0.25 0.50 0.76 1.01           268  
DEET 0.00 0.25 0.50 0.75 1.00           192  
Atorvastatin 0.00 0.25 0.50 0.75 1.00           580  
Trimethoprim 0.00 0.25 0.50 0.75 1.01           292  
NDMA 0.00 0.25 0.50 0.75 1.00             74  
Perchlorate (Na) 0.00 29.10 58.19 87.29 116.38     14,250  
 
2.6 Bench-scale Tests 
Both conventional treatment techniques and advanced treatment techniques were 
evaluated in this study. The conventional drinking water treatment techniques include 
coagulation, flocculation, sedimentation, media filtration and chlorination. Bench scale 
experiments were designed to closely simulate the conditions used in each full-scale plant.  
When possible, the actual filter or adsorbent media were collected from the full-scale plant 
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for use in bench-scale treatment. The chemical dosage and the contact time were adjusted 
according to the volume of water used in the bench scale experiment. 
Chlorination was performed in the laboratory by adding the requisite volume of a 
concentrated chlorine stock solution to the full volume of water that was to be treated.   
For more information on chlorination procedures, the reader should consult the 
UMass Standard Operating Procedures (SOP) for laboratory chlorination 
(http://www.ecs.umass.edu/eve/research/sop/). 
Coagulation was performed in the laboratory using the same coagulant (e.g., 
aluminum sulfate salt (Alum), [Al2(SO4)3.14H2O], poly aluminum chloride (PACl), ferric 
chloride( FeCl3), ferric sulfate(Fe2(SO4)3)) and coagulant aid at the same dose as was used in 
the full-scale plant Coagulant used in this study was obtained from the actual treatment plant. 
Flocculation was done with a slow mix impeller.  In 1L beakers, a paddle was rotated at 30 
rpm for 1 hour. Settling immediately followed flocculation in the same vessel and lasted 4 
hours.   
Filtration was performed in the laboratory using wherever possible a sample of the 
actual media used in the full-scale plant, (e.g sand and anthracite coal, granular activated 
carbon collected at the time of raw water sampling). Filtration was done on laboratory liquid 
chromatography (LC) columns. Empty bed contact time was adjusted according to the water 
volume used in this study and was designed to replicate the EBCT of the full-scale plant. 
Settled water was pumped through the column at the adjusted flow rate. 
Ozonation was performed by a batch method using a concentrated aqueous ozone 
solution.  The ozone stock solution was prepared in the lab the by semi-continuous ozonation 
of deionized water acidified to pH 2 with reagent grade HCl. The concentration of the ozone 
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stock solution was calculated by measuring the absorbance at 260 nm and using an 
absorptivity of 3000 M-1cm-1,  (C [mg/L] = 16*abs).   A Welsbach corona ozone generator 
was used to generate ozone from pure dry oxygen.  The gas was directed into a glass vessel 
through stainless steel tubing and switching valves.  The proper ratio of ozone stock solution 
to sample was used to achieve the desired dose in mg-O3 per liter of sample volume.  The 
sample was then allowed to react until the residual ozone had dissipate.  The ozone contact 
time using of the real treatment plant was adjusted according to the actual volume of the 
water used in the study. The ozone residual was determined by periodically recording the UV 
absorbance of the ozonated sample at 254 nm.   
2.7 Analytical Methods 
2.7.1 Total and Dissolved Organic Carbon 
The analysis of total and dissolved organic carbon was based on the standard 
combustion technique in accordance with Method 5310 of Standard Methods (APHA et al., 
2005). Detailed operations were summarized in the UMass standard Operating Procedure 
(SOP) for Organic Carbon. Measurement was conducted using a Shimadzu TOC-VCPH Total 
Organic Carbon Analyzer. Approximately 12 mL of sample was collected for analysis. 
Samples for the analysis of dissolved organic carbon were filtered through a pre-rinsed 0.45 
micron Whatman GF/F glass fiber filter. The pH of the samples was adjusted to pH 2 before 
the analysis. A stock solution of 1000 mg/L potassium hydrogen phthalate was used to 
prepare the calibration standard. 
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2.7.2 Ultraviolet (UV) Absorbance  
The analysis of UV absorbance was based on Method 5910 of Standard Methods, and 
is described in the UMass standard Operating Procedure for UV absorbance. Samples were 
placed in the 1-cm Cuvettes and measured using an Agilent 8453 UV Visible System 
analyzer. A full scan of the absorbance was recorded. 
Specific UV absorbance (SUVA) is defined as the UV absorbance of a sample at a 
specific wavelength normalized by dissolved organic carbon (DOC) concentration. It is 
calculated based on UV absorbance at 254 nm and DOC in this study.  
2.7.3 Trihalomethane Analysis 
The extraction and measurement of trihalomethanes was based on US EPA Method 
551.1, “Determination of Chlorination Disinfection Byproducts, Chlorinated Solvents and 
Halogenated Pesticides/Herbicides in Drinking Water by Liquid-Liquid Extraction and Gas 
Chromatography with Electron Capture Detection,” and it is described in the UMass SOP for 
Trihalomethane measurement. 20 mL samples were transferred to 40 mL acid washed amber 
vials. Standards were prepared by adding appropriate amount of pre-made volatile organic 
mix to 20 mL of deionized water. The volatile organic mix contains four species of THM, 
and they are listed in Table 2.8.  
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Table 2.8: Standard THM Analytes 
Thihalomethanes 
Analyte CAS Registry # 
Chloroform (CHCl3) 67-66-3 
Bromodichloromethane (CHCl2Br) 75-27-4 
Chlorodibromomethane (CHClBr2) 124-48-1 
Bromoform (CHBr3) 75-25-2 
The extraction procedure includes the following steps: 
 Add 4 mL of the pre-mixed Pentane plus internal standard (1, 2-dibromopropane), add 
approximately 15 g of Na2SO4 to each vial and then shake for 15 minutes.  
 Transfer organic layer (top) to 2 mL crimp top vials, freeze to remove water and analyze.  
An Agilent 6890 gas chromatograph was used in connection with ChemStation 
computer control.  The GC was equipped with a linearized 63Ni electron capture detector.  
Concentrations were determined from a calibration curve with peak and ratios (to the internal 
standard) of extracts prepared from aqueous calibration standards plotted versus aqueous 
concentration. 
2.7.4 Haloacetic Acid Extraction 
The extraction and measurement of Haloacetic Acids was based on the US EPA 
Method 552.2, “Determination of Haloacetic Acids and Dalapon in drinking Water by 
Liquid-Liquid Extraction, Derivatization, and Gas Chromatography with the Electron 
Capture Detection”. At the end of the chlorine or chloramine contact time the quenched 
samples for HAA analysis were stored at 4°C for no more than 14 days before extraction. 30 
mL samples were transferred to 40 mL acid washed clear vials. Standards were prepared by 
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adding appropriate amount of pre-made organic mix to 30 mL of deionized water. The 
organic mix contained nine species of HAA, and they are listed in Table 2.9. 
Table 2.9: Standard HAA Analytes 
Analyte CAS Registry # 
Thihaloacetic Acids (THAA) 
Trichloroacetic Acid (TCAA) 76-03-9 
Bromodichloroacetic Acid (BDCAA) 7113-314-7 
Chlorodibromoacetic Acid (CDBAA) 5278-95-5 
Tribromoacetic Acid (TBAA) 75-96-7 
Dihaloacetic Acids (DHAA) 
Dichloroacetic Acid (DCAA) 79-43-6 
Bromochloroacetic Acid (BCAA) 5589-96-3 
Dibromoacetic Acid (DBAA) 631-64-1 
Monohaloacetic Acids (MHAA) 
Monochloroacetic Acid (MCAA) 79-11-8 
Monobromoacetic Acid (MBAA) 79-08-3 
  
The extraction procedure included the following steps: 
 Add 1.5 mL concentrated H2SO4 to each vial, add 3mL of the pre-mixed MTBE plus 
internal standard (1, 2, 3-trichloropropane), and then add 15 g of sodium sulfate, 
shake for 15 minutes.  
 Remove 1 mL from first extract and place into prepared 20mL vials containing 2 ml 
of acidic methanol (5% H2SO4) solution and incubate in the 50°C water bath for 2 
hours.  
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 Add 5 mL saturated NaHCO3 solution to each vial, add 1mL pure MTBE and shake 
for 2 minutes.  
 Transfer organic layer (top) to 2 mL crimp top vials, freeze to remove water and 
analyze 
An Agilent 6890 gas chromatograph was used in connection with ChemStation 
computer control.  The GC was equipped with a linearized 63Ni electron capture detector.  
Concentrations were determined from a calibration curve with peak are ratios (to the 
internal standard) of extracts prepared from aqueous calibration standards plotted versus 
aqueous concentration. 
2.7.5 Target Compound Analysis 
2.7.5.1 Solid Phase Extraction 
The solid phase extraction was conducted based on US EPA method 1694, 
“Pharmaceuticals and Personal Care Products in Water, Soil, Sediment, and Biosolids by 
HPLC-MS/MS2.  
2 L samples are collected for acid and base fraction (1 L each) and stored in the 4 
degrees Celsius constant temperature room. Samples were extracted within 48 hours of 
collection. For this study, deionized water was used as the reagent water. 
2.7.5.1.1 Acid Fraction 
The samples were brought to room temperature. The pH of the samples for the acid 
fraction was adjusted to pH 2.0 ± 0.5. Then the samples were spiked with 2 uL of 8 labeled 
target compounds solution. EDTA salt was added to the sample after the spiking. Stabilize 
                                                 
2 Liquid chromatography-mass spectrometry 
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the sample for one to two hours before the extraction. The extraction procedure includes the 
following steps: 
 Extract the compound with HLB cartridges, rinse the cartridge with deionized water 
after all of the sample have gone through the cartridge and elute the cartridge using 
12 mLs HPLC grade methanol.  
 Dry the eluent with nitrogen in the 50 oC water bath and bring the volume back to 4 
mL using methanol. 
2.7.5.1.2 Base Fraction 
The samples were brought to room temperature. The pH of the samples for the base 
fraction was adjusted to pH 10.0 ± 0.5. Then the samples were spiked with the 2 uL of 8 
labeled target compounds. The extraction procedure includes the following steps: 
 Extract the compound with HLB cartridges and elute the cartridge using 6 mL HPLC 
grade methanol and 9 mL 2% formic acid solution.  
 Dry the eluent with nitrogen in the 50 oC water bath and bring the volume back to 4 
mL using methanol and 0.1% formic acid solution.  
2.7.5.2 Instrumental Analysis 
Aqueous standards were prepared using 2 L of deionized water (1 L for each 
extraction), and an appropriate volume of the low level spike solution was added to produce 
0%, 25%, 50%, 75% and 100% of the full raw water low-level spike concentration. 
Samples and standards were analyzed using a liquid chromatograph – mass 
spectrometer (LC/MS). The liquid chromatograph was an Acquity UPLC manufactured by 
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Waters Corporation of Milford MA. The mass spectromter was a Quattro Premier triple 
quadrupole instrument also manufactured by Waters Corporation. 
The instrument was first calibrated with standards prepared directlly in the elution 
solvent. Parent daughter transitions were examined for each compound and in most cases two 
transitions were followed during analysis (Table 2.10 and Table 2.11). Final calibration was 
done with aqueous standard spiked with native and labeled compounds. In most cases 
transitions leading to Daughter 1 were used for quantification. 
Table 2.10: Transitions and Voltages used for ESI3 Positive4 Runs 
Compound Form 
Parent Daughter 1 Daughter 2 
m/z cone m/z collision m/z collision 
Atenolol 
nat2 266.9 34 190.1 19 145 25 
d7 273.9 34 190.1 19 145 25 
Ranitidine 
nat 314.9 26 176 17 145 25 
d6 320.9 26 176 17 123.9 24 
Sulfamethoxazole 
nat 253.9 26 156 16 107.9 21 
d4 257.9 26 160 16 111.9 21 
Trimethoprim 
nat 290.2 42 230 22 123 22 
d9 299.2 42 234 22 123 22 
Ciprofloxacin nat 332.5 35 315.1 20 289.2 20 
TCEP nat 285 30 223 15 161 15 
DEET nat 192.1 30 118.9 19 90.9 19 
Naproxen nat 231 20 185 15 170 30 
                                                 
3 Electrospray Ionisation, one of the Atmospheric Pressure Ionisation (API) techniques and is well-
suited to the analysis of polar molecules ranging from less than 100 Da to more than 1,000,000 Da in molecular 
mass. 
4 If the sample has functional groups that readily accept a proton (H+) then positive ion detection is 
used. 
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d3 234 20 188 15 173 30 
Atorvastatin 
nat 559 40 440 17 471 17 
d5 564 40 445 17 471 17 
Propranolol 
nat 259.9 34 183.1 18 123 16 
d7 266.9 34 183.1 18 123 16 
 
Table 2.11: Transitions and Voltages used for ESI Negative5 Runs 
Compound Form 
Parent Daughter 1 Daughter 2 
m/z cone m/z collision m/z collision 
Estradiol nat 271.1 60 145 42 183 42
Estrone nat 269.2 60 145 41 143 53
Naproxen nat 228.9 15 185.1 8 170.1 15
Dicflofenac nat 294.2 15 250 10 252 10
 
2.7.5.3 Method Detection Limit 
Full method detection limits were determined by spiking a large volume aqueous 
sample at the level of 6.25 pM. This fortified sample was then split into 10 aliquots and each 
was analyzed as if it was a separate sample. The final quantifications were compiled and the 
MDL was determined from the standard deviation of the replicate measurements in 
accordance with standard procedures (APHA et al., 2005). Table 2.12 summarizes the MDLs 
in molar units (picomoles per liter) and mass units (nanograms per liter). 
 
 
                                                 
5 If the sample has functional groups that readily lose a proton then negative ion detection is used.  
29 
 
Table 2.12: Method Detection Limits for the Target Analytes 
Analyte pM ng/L 
Naproxen 1.78 0.4
Estrone 1.72 0.5
Sulfamethoxazole 1.10 0.3
Atorvastatin 6.77 3.9
Atenolol 8.13 2.2
Ranitidine 7.80 2.5
Trimethoprim 0.78 0.2
DEET 8.48 1.6
Propanolol 0.44 0.1
Ciprofloxacin 1.60 0.5
TCEP 0.75 0.2
 
2.8 Field Sampling 
2.8.1 Water 1 
This utility uses water from a small surface supply. There are indications that this 
supply has seasonal algal problems. Average raw water TOC values are about 4 mg/L, but 
levels as high as 7 mg/L have been recorded. Alkalinity is typically about 20 mg/L, and pH is 
6.8. Iron levels average 0.2 mg/L, but can spike to 0.6 mg/L. 
Eight raw water samples (three 20-L; five 2-L) were collected from utility #1 as listed 
below. The large samples were collected in polyethylene carboys, and the smaller ones were 
in borosilicate glass with Teflon-lined caps. Two one-liter volumes of GAC were collected 
from the top layer of an operating filter by means of a long-handled Teflon scooper. In 
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addition, two samples were transferred and returned as travel/field blanks. The samples were 
collected at about 3:00 PM on Thursday, June 25, 2009. 
 Three 20L Carboys of raw water 
 Four 2L glass bottles of raw water 
 Two 2L glass bottles of travel blank (labeled #1x) 
 One 2L glass bottle with finished water (for immediate biotesting) 
 Two 1L blue plastic (Calgon) bottles of GAC media 
2.8.2 Water 2 
This utility uses water from a series of wells.  At least one of the wells is located on 
the edge of a pond and may be heavily impacted by surface water. 
Six raw water samples (two 20-L; four 2-L) were collected from utility #2 as listed 
below. The large samples were collected in polyethylene carboys, and the smaller ones were 
in borosilicate glass with Teflon-lined caps. The samples were collected at about 3:00 PM on 
Wednesday, May 6, 2009. 
 Two 20 L carboys of separate raw water sources at utility #2 (labeled 2A and 2B).   
 Three 2L glass bottles of raw water (two labeled 2A, one 2B).   
 One 2L glass bottle of travel blank (labeled 2X).  
2.8.3 Water 3 
This utility uses water from several wells and surface water. The approximate usage 
rates for the sources are about two-thirds from the surface supply and about one-third from 
the various wells. For this work, only the surface water and one well were sampled. The 
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particular utility has a waiver from filtration, so chlorination and hydroxide addition are the 
only treatments used. 
Six raw water samples (three 20-L; three 2-L) were collected from utility #3 as listed 
below. The large samples were collected in polyethylene carboys, and the smaller ones were 
in borosilicate glass with teflon-lined caps. In addition, one sample was transferred and 
returned as a travel/field blank. The samples were collected at about 11:30 AM on Thursday, 
July 30, 2009. 
 One 20L Carboy of raw groundwater 
 Two 20L Carboys of raw surface water 
 One 2L glass bottle of raw groundwater 
 Two 2L glass bottles of raw surface water 
 One 2L glass bottle of travel blank (labeled #3x) 
2.8.4 Water 4 
This utility uses water from several wells. For this work, only one well was sampled. 
As with many groundwater supplies, disinfection isn’t required, therefore no chlorine or 
chloramines are normally added. Similarly filtration isn’t required, so no coagulants are 
added. 
Six raw water samples (three 20-L; three 2-L) were collected from utility #4 as listed 
below. The large samples were collected in polyethylene carboys, and the smaller ones were 
in borosilicate glass with teflon-lined caps. In addition, one sample was transferred and 
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returned as a travel/field blank. The samples were collected at about 9:30 AM on Thursday, 
July 30, 2009. 
 Three 20L Carboys of raw water 
 Three 2L glass bottles of raw water 
 One 2L glass bottle of travel blank (labeled #4x) 
2.8.5 Water 5 
Nine raw water samples (three 20-L; six 1-L) were collected from utility #5.  The 
large samples were collected in polyethylene carboys, and the smaller ones were in 
borosilicate glass with teflon-lined caps.  The samples were collected on Tuesday, March 23, 
2010.  All samples came from the plant influent. 
2.8.6 Water 7 
Two 20 L samples were collected from an inside tap at this utility, and three 2L 
samples were collected directly from the reservoir using a submersible 1-L sample bottle.  A 
fourth was collected at the same time using the same sampler.  The samples were collected at 
about 3:00 PM on Friday, March 20, 2009.   
2.8.7 Water 8 
Six raw water samples (three 20-L; three 2-L) were collected from utility #8.  The 
large samples were collected in polyethylene carboys, and the smaller ones were in 
borosilicate glass with teflon-lined caps.  The samples were collected on Tuesday, April 6, 
2010.  All samples came from the plant influent.  In addition a 1-liter volume of the in-
service Anthracite media was collected. 
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2.8.8 Water 9 
Seven raw water samples (two 20-L; five 1-L) were collected from utility #9. The 
large samples were collected in polyethylene carboys, and the smaller ones were in 
borosilicate glass with teflon-lined caps. The samples were collected on Tuesday, June 16, 
2009. All samples came from the plant influent. 
2.8.9 Water 10 
Two 20 L samples were collected from an inside tap at this utility.  At the same time 
three 2L samples were collected in glass from the same inside tap.  The samples were 
collected at about 2:00 PM on Monday, April 13, 2009. 
2.8.10 Water 11 
This utility uses water from as many as 9 wells. For this work, only one well was 
sampled, #3A. As with many groundwater supplies, filtration isn’t required, so no coagulants 
are added. 
Additional wells and storage were added through the years. Well 1 was abandoned 
because of sodium contamination in 1961. The system currently consists of 9 gravel packed 
wells, 4 of which receive greensand filtration for iron and manganese at 2 filtration plants. 
The system has 4 storage tanks. All finish water receives chlorination by either gas or 
hypochlorite for disinfection and either potassium hydroxide or sodium hydroxide for pH 
control. Sodium fluoride is added to prevent tooth decay. The system consists of 
approximately 140 miles of main ranging in diameter from 4” to 16”. The wells have the 
ability to pump 6.5 mgd. The average system flow for 2008 was 1.76 mgd. 
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2.8.11 Water 12 
Two 20 L samples were collected from this utility, each from the in-plant raw water 
tap.  The samples were collected at about 11:00 AM on Friday, January 16, 2009.   
2.8.12 Water 13 
Two 20 L samples were collected from this utility, each from the in-plant raw water 
tap.  The samples were collected at about 3:00 PM on Tuesday, February 3, 2009.   
2.8.13 Water 14 
Two 20 L samples were collected from this utility, each from a different plant 
(designated A and B).  The samples were collected at about 5:00 -6:00 PM on Thursday, 
November 20, 2008.  Because of the enclosed nature of the greensand pressure filters, I was 
unable to obtain a sample of the active filtration media.  As a result, I was not able to fully 
simulate this process in the laboratory.  Instead I used standard filtration (glass fiber/fine) to 
achieve particle removal.  
2.8.14 Water 15 
Nine raw water samples (six 20-L; three 2-L) were collected from utility #15 as listed 
below. The large samples were collected in polyethylene carboys, and the smaller ones were 
in borosilicate glass with Teflon-lined caps. In addition, one sample was transferred and 
returned as a travel/field blank. The samples were collected at about 10:30 AM on Tuesday, 
September 15, 2009. 
 Six 20L Carboy of raw water (low form: B5, B6, B7 B8, and tall blue, tall turquoise) 
 Three 2L glass bottles of raw water 
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 One 2L glass bottle of travel blank (bottle #31; labeled #15x) 
2.8.15 Water16 
This utility uses water from a reservoir. There is a 4-mile transmission main from the 
reservoir to the water treatment plant. There are also three groundwater wells nearby that are 
used to supplement the surface water source. It uses monomedia (sand) filtration, at rates of 
about 1.5 gpm/ft2. There is a 290,000 gal clear well, and a very long typical water age in the 
system. The operator offered an estimate of 8-12 days. The typical plant flow is 3.5 MGD. 
Two 20 L samples were collected from an inside tap at this utility. At the same time 
three 2L samples were collected in glass from the same inside tap. The samples were 
collected at about 4:00 PM on Monday, April 13, 2009. 
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CHAPTER 3 RESULTS AND DATA ANALYSIS 
3.1 Analysis of ambient concentrations 
3.1.1 Ambient concentrations in raw water from utilities 
While not a major focus of this research project, one of the sub-tasks was to measure 
ambient concentrations of the target compounds in the raw water samples collected for each 
utility. The concentrations below are in units of pM and ng/L. Values reported here are 
within those that have been reported in the literature for natural surface waters.  
Utility #15 was recognized as one that used raw water impacted by wastewater. The 
data in Table 3.1 and Table 3.2 support this contention. Data from other utilities are similarly 
in agreement with the presumed level of protection from anthropogenic contaminants.  
 Table 3.1:  Raw Water Ambient Concentrations of Target Compounds (pM) 
Analyte #1 #2 #3 #4 #5 #8 #9 #10 #11 #12 #14 #15 
Naproxen 2.1 3.1 27.5 BDL BDL BDL 22.7 12.8 259.1 109.9 BDL 32.5 
Estrone 7.1 BDL 3.1 BDL 5 BDL 5.9 92.4 BDL BDL BDL 7.9 
Sulfamethoxazole 18.4 N/A 7.7 BDL BDL BDL BDL 143 BDL BDL BDL 110 
Atorvastatin BDL BDL BDL BDL BDL BDL BDL BDL BDL 30.9 BDL 53.4 
Atenolol 144 N/A BDL BDL BDL BDL BDL BDL BDL BDL BDL 249 
Ranitidine BDL BDL BDL BDL BDL BDL 15.2 33.2 BDL BDL BDL BDL 
Trimethoprim 12 1.5 1.7 BDL BDL BDL BDL BDL 4.3 BDL BDL 26.9 
DEET 42.2 BDL 946 BDL 25.8 175.8 126 693 18.6 430 BDL 92 
Propanolol 1.3 5.5 0.9 BDL BDL BDL 1.7 2.5 BDL 31.6 BDL 3.9 
Ciprofloxacin 42.2 BDL 111 BDL 96.4 BDL 230 BDL 17.6 BDL BDL 541 
TCEP BDL N/A BDL 22.8 31.4 BDL BDL BDL 9.9 N/A BDL BDL 
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Table 3.2:  Raw Water Ambient Concentrations of Target Compounds (ng/L) 
Analyte #1 #2 #3 #4 #5 #8 #9 #10 #11 #12 #14 #15 
Naproxen 0.5 0.7 6.3 BDL BDL BDL 5.2 2.9 59.7 25.3 BDL 7.5 
Estrone 1.9 BDL 0.8 BDL 1.4 BDL 1.6 25 BDL BDL BDL 2.1 
Sulfamethoxazole 4.7 N/A 2 BDL BDL BDL BDL 36.2 BDL BDL BDL 27.8 
Atorvastatin BDL BDL BDL BDL BDL BDL BDL BDL BDL 17.9 BDL 31 
Atenolol 38.3 N/A BDL BDL BDL BDL BDL BDL BDL BDL BDL 66.2 
Ranitidine BDL BDL BDL BDL BDL BDL 4.8 10.4 BDL BDL BDL BDL 
Trimethoprim 3.5 0.4 0.5 BDL BDL BDL BDL BDL 1.2 BDL BDL 7.8 
DEET 8.1 BDL 181 BDL 4.9 33.6 24.1 133 3.6 82.3 BDL 17.6 
Propanolol 0.3 1.4 0.2 BDL BDL BDL 0.4 0.6 BDL 8.2 BDL 1 
Ciprofloxacin 14 BDL 36.7 BDL 31.9 BDL 76.1 BDL 5.8 BDL BDL 179 
TCEP BDL N/A BDL 6.5 9 BDL BDL BDL 2.8 N/A BDL BDL 
 
3.2 INDIVIDUAL SITE SPECIFIC TESTS 
In the pages that follow, I present the laboratory results one utility at a time. 
The testing protocol is summarized for each utility in a flow diagram that has points 
of chemical addition and doses. This is followed by conventional parameters in tabular and 
graphical format. Absorbance spectra are shown for raw, partially treated and finished water. 
These could help the interpretation of the effectiveness for different treatment processes, 
mostly for the removal of natural organic matter (NOM), especially NOM that with a strong 
aromatic signature. Then the target compounds analysis is presented in a graphical format, 
showing the relative concentration (compared to the concentration in the raw water which is 
defined as 100% remaining) of each individual compound at various stages of treatment. The 
use of relative concentrations is to facilitate comparisons across compounds and especially 
across dosing levels (high level vs. low level). In many cases these graphs do not show all 
target compounds. Compounds are omitted due to poor recovery or other QC failures which 
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are specific to a particular sample set, compound or utility. In many cases, the presentation 
ends with a graph or two showing regulated and non-regulated disinfection byproducts 
(DBPs) produced by the bench-scale treatment. Again this is used as a benchmark to help in 
interpreting the laboratory testing. 
All the participating utilities are classified by treatments as shown below. 
3.2.1 Utilities with minimum treatment 
3.2.1.1 Water 2  
As mentioned in Chapter 2, this is water from a series of wells and at least one of the 
wells is located on the edge of a pond and may be heavily impacted by surface water.  
Figure 3.1 shows the treatment sequence and doses used in the bench-scale tests with 
water #2.  Three liters of the raw water was used for the high level spike study and ten liters 
of the raw water was used for the low level spike study considering the extra water needed 
for the solid phase extraction (SPE). 
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Table 3.3: Basic Water Quality Parameters: Water #2: High Level Spike 
Testing Parameter Raw Finished  
pH 6.54 9.87 
Turbidity (NTU) 0.14 0.17 
Cl2 Residual (mg/L) N/A6 0.22 
TOC (mg/L) 0.94 1.46 
DOC (mg/L) 0.88 1.52 
Total N (mg/L) 2.09 2.15 
Dissolved N (mg/L) 1.99 1.96 
UV abs (/cm) 0.01 0.04 
SUVA (L/mg-m) 0.91 2.39 
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Figure 3.2: General Water Quality for Raw and Treated Water from Utility #2: High 
Level Spike 
Figure 3.3 shows that there was an increase of UV absorbance (from 0.01 to 0.04) in 
the finished water. Some of this increase may be due to absorbance by the sodium 
                                                 
6 Otherwise indicated, N/A represents not measured in this document. 
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hexametaphosphate. More likely, it is due to higher charge on the NOM from the high pH, 
resulting in a more extended configuration and higher molecular absorptivity. 
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Figure 3.3: Absorbance Spectra for Raw and Treated Water from Utility #2: High 
Level Spike 
Disinfection byproduct analysis (Figure 3.4) showed a substantial formation of THMs 
with a far lower formation of HAAs. The preferential formation of THMs was expected for 
waters chlorinated at high pH as this was.   
Major DBP Species
THMs MHAA DHAA THAA
C
on
ce
nt
ra
tio
n 
( g
/L
)
0
10
20
30
40
50
60
CHCl3 
CHCl2Br 
CHClBr2 
CHBr3 
MCAA 
MBAA 
DCAA 
BCAA 
DBAA 
TCAA 
BDCAA 
CDBAA 
 
Figure 3.4: Major DBP Species for Finished Water from Utility #2: High Level Spike 
The target compound analysis (Figure 3.5) shows the complete removal of atenolol, 
ranitidine, trimethoprim, ciprofloxacin, naproxen and atorvastatin. Chlorination has little 
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effect on removing DEET, as this compound was found at remain 88% of its original 
concentration in the finished water. 
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Figure 3.5: Target Compound Concentrations Expressed as %Remaining for Utility #2: 
High Level Spike 
3.2.2.1.2 Water 2: Low Level Spike 
The low level spike experiment was conducted in exactly the same fashion as the high 
level spike, except that a larger volume had to be used in order to accommodate the large 
sample volumes needed for solid phase extraction (SPE). 
As with the high-level testing, the pH was substantially increased by the addition of 
potassium hydroxide in accordance with the full-scale treatment. It had a low TOC level 
which increased after the addition of the spike solution.  Subsequent treatment with chlorine, 
caustic and phosphate had no measureable effects on NOM concentrations. Compared to the 
high level spike test, SUVA had less increase in the finished water at 73% (Table 3.4, Figure 
3.6).  
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Table 3.4: Basic Water Quality Parameters: Water #2: Low Level Spike 
Testing Parameter Raw Finished  
pH 6.54 9.72 
Turbidity (NTU) 0.14  0.18  
Cl2 Residual (mg/L) N/A 0.49 
TOC (mg/L) 0.941 0.96 
DOC (mg/L) 0.881 0.98  
Total N (mg/L) 2.09 2.11  
Dissolved N (mg/L) 1.99  1.99  
UV abs (/cm) 0.01  0.02  
SUVA (L/mg-m) 0.91 1.63 
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Figure 3.6: General Water Quality for Raw and Treated Water from Utility #2: Low 
Level Spike 
Again there was a small amount of increase of UV absorbance, probably as a result of 
an artifact of the pH and the direct absorbance of the chemical additives (Figure 3.7). 
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Figure 3.7: Absorbance Spectra for Raw and Treated Water from Utility #2: Low Level 
Spike 
Disinfection byproduct analysis (Figure 3.8) shows substantial formation of THMs 
with a far lower formation of HAAs.  As with the high-level spike, the preferential formation 
of THMs is expected for waters chlorinated at high pH.  In this case the HAAs and THMs 
were about the same as those produced in the high-level spike tests.   
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Figure 3.8: Major DBP Species for Finished Water from Utility #2: Low Level Spike 
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The target compound analysis (Figure 3.9) shows nearly complete removal of five 
target compounds: ranitidine, sulfamethoxazole, ciprofloxacin, naproxen and atorvastatin. 
Trimethoprim was removed by 44% while DEET was still resistant to the treatment. 
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Figure 3.9: Target Compound Concentrations Expressed as %Remaining for Utility #2: 
Low Level Spike 
3.2.1.2 Water 3 
The raw water is from several wells and surface water. The approximate usage rates 
for the sources are about two-thirds from the surface supply and about one-third from the 
various wells. For this work, only the surface water and one well were sampled. This 
particular utility has a waiver from filtration, so chlorination and hydroxide addition are the 
only treatments used. 
Six raw water samples (three 20-L; three 2-L) were collected from utility #3. The 
large samples were collected in polyethylene carboys, and the smaller ones were in 
borosilicate glass with teflon-lined caps. In addition, one sample was transferred and returned 
as a travel/field blank. The samples were collected at about 11:30 AM on Thursday, July 30, 
2009. 
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Table 3.5: Basic Water Quality Parameters: Water #3: High Level Spike 
Testing Parameter Raw Chlorinated Finished  
pH 7.70 N/A 10.55 
Turbidity 0.33 N/A N/A 
Cl2 Residual 
(mg/L) 
N/A 1.67 N/A 
TOC (mg/L) 1.64 N/A 1.96 
DOC (mg/L) 1.64 N/A 1.94 
Total N (mg/L) 0.15 N/A N/A 
Dissolved N 
(mg/L) 
0.16 N/A N/A 
UV abs (/cm) 0.03 N/A 0.03 
SUVA (L/mg-m) 1.80 N/A 1.40 
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Figure 3.11: General Water Quality for Raw and Treated Water from Utility #3: High 
Level Spike 
Figure 3.12 shows a small increase of UV absorbance through the treatment which 
may be attributed to some colloid formation and resultant scattering of light, rather than true 
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absorbance. The UV absorbance of the finished water had a very high intensity (more than 
0.4 cm-1) below wavelength 220 nm. 
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Figure 3.12: Absorbance Spectra for Raw and Treated Water from Utility #3: High 
Level Spike 
Target compound analysis (Figure 3.13) showed near complete removal of all PPCP 
compounds except for DEET and TCEP which remain 90% and 98% in the finished water 
respectively. The removal of naproxen was around 90%. 
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Figure 3.13: Target Compound Concentrations Expressed as %Remaining for Utility 
#3: High Level Spike 
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3.2.1.2.2 Water 3: Low Level Spike 
The low level spike experiment was conducted in exactly the same fashion as the high 
level spike, except that a larger volume had to be used in order to accommodate the large 
sample volumes needed for solid phase extraction (SPE). 
As with the high-level testing, the pH was substantially elevated from 7.7 to 10.23 
after the addition of sodium hydroxide. The raw water had a low TOC level which increased 
after addition of the spike solution.  Again, treatment with chlorine and caustic had no 
measureable effects on NOM concentrations (Table 3.6, Figure 3.14).  
Table 3.6: Basic Water Quality Parameters: Water #3: Low Level Spike 
Testing Parameter Raw Chlorinated Finished  
pH 7.70 N/A 10.23 
Turbidity 0.33 N/A N/A 
Cl2 Residual (mg/L) N/A 1.36 N/A 
TOC (mg/L) 1.64 N/A 1.58 
DOC (mg/L) 1.64 N/A 1.56 
Total N (mg/L) 0.15 N/A N/A 
Dissolved N (mg/L) 0.16 N/A N/A 
UV abs (/cm) 0.03 N/A 0.01 
SUVA (L/mg-m) 1.80 N/A 0.87 
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Figure 3.14: General Water Quality for Raw and Treated Water from Utility #3: Low 
Level Spike 
Figure 3.15 shows a 50% loss or destruction of UV absorbance, likely attributable to 
the bleaching effect of chlorine. 
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Figure 3.15: Absorbance Spectra for Raw and Treated Water from Utility #3: Low 
Level Spike 
Analysis of the target compounds in the low level spike experiments (Figure 3.16) 
showed similar patterns of removal as compared to the high level experiments but the 
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remaining concentration of estrone was much higher.   Except for DEET and TCEP, 
extensive loss of all target compounds was noted. Of the remaining compounds naproxen and 
ranitidine seemed to be less completely removed (~90%). 
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Figure 3.16: Target Compound Concentrations Expressed as %Remaining for Utility 
#3: Low Level Spike 
3.2.1.3 Water 4 
Utility #4 uses water from several wells. For this work, only one well was sampled. 
As with many groundwater supplies, disinfection isn’t required, therefore no chlorine or 
chloramines are normally added. Similarly filtration isn’t required, so no coagulants are 
added. 
Figure 3.17 shows the treatment sequence and doses used in bench-scale tests with 
water #4. 3L of the raw water was used for the high level spike study and ten liters of the raw 
water was used for the low level spike study considering the extra water needed for the solid 
phase extraction (SPE). 
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Table 3.7: Basic Water Quality Parameters: Water #4: High Level Spike 
Testing Parameter Raw Finished  
pH 5.32 6.61 
Turbidity 0.062 N/A 
Cl2 Residual (mg/L) N/A N/A 
TOC (mg/L) 1.80 2.39 
DOC (mg/L) 1.80 2.31 
Total N (mg/L) 3.85 N/A 
Dissolved N (mg/L) 3.60 N/A 
UV abs (/cm) 0.01 0.04 
SUVA (L/mg-m) 0.60 1.78 
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Figure 3.18: General Water Quality for Raw and Treated Water from Utility #4: High 
Level Spike 
The raw water absorbance spectrum is featureless (Figure 3.19). There was a small 
amount increase of UV absorbance, with high intensities below 230nm. The finished 
54 
 
spectrum shows definite signs of light scattering (broad attenuation well into the visible 
range). This may be an indication of metal oxide colloids (e.g., Fe/Mn). 
Wavelength (nm)
200 220 240 260 280 300 320 340
A
bs
or
ba
nc
e 
(c
m
-1
)
0.0
0.2
0.4
0.6
0.8
1.0
1.2
Raw 
Finished
Wavelength (nm)
240 245 250 255 260 265 270
Ab
so
rb
an
ce
 (c
m
-1
)
0.00
0.02
0.04
0.06
0.08
0.10
 
Figure 3.19: Absorbance Spectra for Raw and Treated Water from Utility #4: High 
Level Spike 
Target compound analysis (Figure 3.20) showed almost no removal of all the target 
compounds. This is to be expected for waters where the only treatment is caustic addition for 
corrosion control. None of the target compounds are expected to be susceptible to weak 
alkaline hydrolysis. There may have been some loss of estrone, possibly due to sorption to 
metal colloids. 
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Figure 3.20: Target Compound Concentrations Expressed as %Remaining for Utility 
#4: High Level Spike 
3.2.1.3.2 Water 4: Low Level Spike 
The low level spike experiment was conducted in exactly the same fashion as the high 
level spike, except that a larger volume had to be used in order to accommodate the large 
sample volumes SPE (Figure 3.17). 
As with most ground waters, the raw water has a low TOC level as well as SUVA. 
The pH was increased by the addition of potassium hydroxide. In this case, TOC 
concentration decreased in the finished water (Table 3.8, Figure 3.21) but no real change in 
the UV absorbance (Figure 3.22).   
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Table 3.8: Basic Water Quality Parameters: Water #4: Low Level Spike 
Testing Parameter Raw Finished  
pH 5.32 7.60 
Turbidity 0.06 N/A 
Cl2 Residual (mg/L) N/A N/A 
TOC (mg/L) 1.80 0.77 
DOC (mg/L) 1.80 0.75 
Total N (mg/L) 3.85 N/A 
Dissolved N (mg/L) 3.60 N/A 
UV abs (/cm) 0.01 0.01 
SUVA (L/mg-m) 0.60 1.75 
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Figure 3.21: General Water Quality for Raw and Treated Water from Utility #4: Low 
Level Spike 
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Figure 3.22: Absorbance Spectra for Raw and Treated Water from Utility #4: Low 
Level Spike 
Target compound analysis (Figure 3.23) showed some modest removal of 
trimethoprim and naproxen, whereas the other was barely affected. As with the high dose 
tests, the small amount of removal suggested in Figure 3.23 may be a result of sorption to 
metal oxide colloids. Sorptive loss could be more extensive in these experiments as the ratio 
of the oxide surface to the target compound concentration is likely to be much higher in the 
low spike tests. 
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Figure 3.23: Target Compound Concentrations Expressed as %Remaining for Utility 
#4: Low Level Spike 
3.2.1.4 Water 5 
Nine raw water samples (three 20-L; six 1-L) were collected from utility #5. The 
large samples were collected in polyethylene carboys, and the smaller ones were in 
borosilicate glass with teflon-lined caps. The samples were collected on Tuesday, March 23, 
2010. All samples came from the plant influent. This utility uses groundwater of moderate 
alkalinity and moderate to high hardness. Nitrate levels are reported to average about 11 
mg/L and ammonia is about 0.9 mg/L. 
Figure 3.24 shows the treatment sequence and doses used in the bench-scale tests 
with water #5. Three liters of the raw water was used for the high level spike study and ten 
liters of the raw water was used for the low level spike study considering the extra water 
needed for the solid phase extraction (SPE). 
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Table 3.9: Basic Water Quality Parameters: Water #5: High Level Spike 
Testing Parameter Raw Finished  
pH 7.40 6.61 
TOC (mg/L) 0.87 1.07 
DOC (mg/L) 0.86 1.15 
Total N (mg/L) 12.89 N/A 
Dissolved N (mg/L) 12.83 N/A 
UV abs (/cm) 0.02 0.03 
SUVA (L/mg-m) 2.04 2.70 
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Figure 3.25: General Water Quality for Raw and Treated Water from Utility #5: High 
Level Spike 
The absorbance spectra (Figure 3.26) shows small increases in the finished water that 
may reflect light-scattering from oxidation of reduced metals during chlorination. 
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Figure 3.26: Absorbance Spectra for Raw and Treated Water from Utility #5: High 
Level Spike 
While most of the compounds were completely removed during the treatment process, 
nearly 30% of atorvastatin remained in the finished water, and more than 70% of the DEET 
persisted (Figure 3.27). 
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Figure 3.27: Target Compound Concentrations Expressed as %Remaining for Utility 
#5: High Level Spike 
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3.2.1.4.2 Water 5: Low Level Spike 
The low level spike experiment was conducted in exactly the same fashion as the high 
level spike, except that a larger volume had to be used in order to accommodate the large 
sample volumes needed for solid phase extraction (SPE) (Figure 3.24). 
As with most ground waters, it had a relatively low TOC level. Different from the 
high level spike test, a loss of 35% TOC was noted through chlorination (Table 3.10, Figure 
3.28).  Figure 3.29 shows that there was a barely perceptible decrease in UV absorbance 
across treatment, presumably due to some chlorine bleaching. 
Table 3.10: Basic Water Quality Parameters: Water #5: Low Level Spike 
Testing Parameter Raw Finished  
pH 7.40 7.54 
Turbidity 0.088 N/A 
Cl2 Residual (mg/L) N/A N/A 
TOC (mg/L) 0.87 0.57 
DOC (mg/L) 0.86 0.58 
Total N (mg/L) 12.89 N/A 
Dissolved N (mg/L) 12.83 N/A 
UV abs (/cm) 0.02 0.02 
SUVA (L/mg-m) 2.04 2.91 
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Figure 3.28: General Water Quality for Raw and Treated Water from Utility #5: Low 
Level Spike 
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Figure 3.29: Absorbance Spectra for Raw and Treated Water from Utility #5: Low 
Level Spike 
Similar to the high level spike study, 60% of DEET remained in the finished water. 
TCEP showed a strong resistance to chlorination. Other compounds are almost completely 
removed by chlorine (Figure 3.30). 
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Figure 3.30: Target Compound Concentrations Expressed as %Remaining for Utility 
#5: Low Level Spike 
3.2.2 Utilities with filtration 
3.2.2.1 Water 1 
Figure 3.31 shows the treatment sequence and doses used in the bench-scale tests 
with water #1. As previously mentioned in Chapter 2, this water is from a small surface 
supply. It was treated with permanganate prior to coagulation, pre-chlorination, gravity 
settling, GAC filtration and final chlorination. 3L of the raw water was used for the high 
level spike study and eighteen liters of the raw water was used for the low level spike study 
considering the extra water needed for the solid phase extraction (SPE). 
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compounds), the overall NOM removal is calculated at 38%. If substantial target compound 
DOC remained, the NOM removal would have to have been higher. SUVA was reduced by 
60% after the treatment process (Figure 3.32).  
Table 3.11:  Basic Water Quality Parameters: Water #1, High Level Spike 
Testing Parameter Raw Settled Filtered Finished 
pH 6.60 6.90 7.17 6.98 
Turbidity 0.62 N/A N/A 0.14 
Cl2 Residual (mg/L) N/A N/A N/A N/A 
TOC (mg/L) 3.15 1.84 1.73 1.68 
DOC (mg/L) 2.85 1.79 1.70 1.65 
Total N (mg/L) 1.19 1.11 1.21 1.10 
Dissolved N (mg/L) 1.28 1.18 1.13 1.06 
UV abs (/cm) 0.13 0.05 0.03 0.03 
SUVA (L/mg-m) 4.47 2.51 1.94 1.80 
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Figure 3.32: General Water Quality for Raw and Treated Water from Utility #1: High 
Level Spike 
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The absorbance spectra are characteristically featureless with high intensities below 
220nm (Figure 3.33).  Extensive pre-oxidation with permanganate and chlorine helped to 
reduce absorbance in the UV range by more than 50%.  Additional absorbance removal was 
observed across GAC filtration, resulting in a monotonic decrease in the bands that are often 
associated with aromaticity (240-270 nm, inset). 
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Figure 3.33: Absorbance Spectra for Raw and Treated Water from Utility #1: High 
Level Spike 
Target compound analysis (Figure 3.34) showed near complete removal of ranitidine 
by pre-oxidation and settling. Filtration across GAC resulted in substantial removals of 
atenolol, DEET and trimethoprim. This was presumably due to biological activity on the 
filters.  Another possible reason for this could be the adsorption on GAC. Final chlorination 
seemed to have resulted in additional losses of trimethoprim, such that only about 1% of the 
atenolol, 2% of the DEET are remaining. 
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Figure 3.34: Target Compound Concentrations Expressed as %Remaining for Utility 
#1: High Level Spike 
3.2.2.1.2 Water 1: Low Level Spike 
The low level spike experiment was conducted in exactly the same fashion as the high 
level spike, except that a larger volume had to be used in order to accommodate the large 
sample volumes needed for solid phase extraction (SPE). 
The changes of the basic water quality parameters (Table 3.12, Figure 3.35) were 
quite similar to what they were in the high level spike study (Table 3.11, Figure 3.32). This 
attests to the reproducibility of the bench scale treatments. The pH stayed around 7.00 during 
the treatment process. If there are any substantial differences between the data sets, it would 
be in the settled water TOC and DOC. But even here, there is very little difference if one 
accounts for the boost in DOC due to the high-level spike itself. Average NOM removal in 
the low-level tests was 29% versus 31% for the high-level tests when corrected for the spike 
DOC. The overall removal through finished water was 32%, as compared to 38% in the high-
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level tests. In addition, the UV absorbance was a lot more extensively removed in the low 
level spike tests (Figure 3.36). 
Table 3.12: Basic Water Quality Parameters: Water #1, Low Level Spike 
Testing Parameter Raw Settled Filtered Finished  
pH 6.60 7.26 7.31 7.42 
Turbidity 0.62 N/A N/A N/A 
Cl2 Residual 
(mg/L) 
N/A N/A 0.08 N/A 
TOC (mg/L) 2.85 1.71 1.86 1.59 
DOC (mg/L) 3.15 1.46 1.61 1.51 
Total N (mg/L) 1.19 1.16 1.44 1.12 
Dissolved N (mg/L) 1.28 1.17 1.17 1.09 
UV abs (/cm) 0.13 0.02 0.02 0.01 
SUVA (L/mg-m) 4.47 1.25 0.95 0.86 
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Figure 3.35: General Water Quality for Raw and Treated Water from Utility #1: Low 
Level Spike 
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Figure 3.36: Absorbance Spectra for Raw and Treated Water from Utility #1: Low 
Level Spike 
Target compound analysis (Figure 3.37) shows near complete removal of ranitidine 
and estrone by pre-oxidation and settling.  GAC filtration resulted in substantial removals of 
atenolol, DEET and atorvastatin.  This was presumably due to biological activity on the 
filters.  Final chlorination seemed to have resulted in additional losses, such that only about 
25% of the trimethoprim, 10% of the DEET was remaining. However, very little of the TCEP 
was removed throughout the treatment with around 90% of the TCEP remained in the 
finished water. These results generally agreed with the high-level testing as both showed 
removal of ranitidine through pre-oxidation and settling. Also removal of atenolol, DEET 
and trimethoprim was demonstrated in both cases through subsequent treatments. 
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Figure 3.37: Target Compound Concentrations Expressed as %Remaining for Utility 
#1: Low Level Spike 
3.2.2.2 Water 8 
Six raw water samples (three 20-L; three 2-L) were collected from utility #8. The 
large samples were collected in polyethylene carboys, and the smaller ones were in 
borosilicate glass with teflon-lined caps. The samples were collected on Tuesday, April 6, 
2010. All samples came from the plant influent. In addition a 1-liter volume of the in-service 
anthracite media was collected. This utility uses an upland supply from a well-protected 
watershed. It is free of substantial anthropogenic sources. 
Figure 3.38 shows the treatment sequence and doses used in the bench-scale tests 
with water #8. Three liters of the raw water was used for the high level spike study and 
eighteen liters of the raw water was used for the low level spike study considering the extra 
water needed for the solid phase extraction (SPE). 
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Table 3.13: Basic Water Quality Parameters: Water #8: High Level Spike 
Testing Parameter Raw Flocculated Filtered Finished  
pH 6.06 6.18 7.78  7.76  
Cl2 Residual 
(mg/L) 
N/A N/A N/A N/A 
TOC (mg/L) 2.66  5.80  4.01 4.01  
DOC (mg/L) 2.63  4.75 3.95 4.07  
Total N (mg/L) 0.18  0.88 0.49 0.46 
Dissolved N (mg/L) 0.18  0.70  0.51  0.44  
UV abs (/cm) 0.11  0.14  0.18 0.18  
SUVA (L/mg-m) 4.11  2.33  4.54  4.49  
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Figure 3.39: General Water Quality for Raw and Treated Water from Utility #8: High 
Level Spike 
The absorbance spectra generally showed an increasing trend from raw water to 
finished water (Figure 3.40).  A small increase in the vicinity of 270 nm was observed in the 
flocculated water, filtered water and finished water. The reasons for which are unclear. 
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Figure 3.40: Absorbance Spectra for Raw and Treated Water from Utility #8: High 
Level Spike 
Target compound analysis showed little removal of the target compounds through 
polymer addition and flocculation (Figure 3.44). Filtration across anthracite/sand media 
resulted in partial removal of atorvastatin. This may due to some biological activity on the 
filter. Final chlorination seemed to have resulted in additional losses, such that 
sulfamethoxazole, trimethoprim, atorvastatin and estrone were nearly completely removed. 
Again, TCEP and DEET showed strong resistance to removal by the treatment process. 
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Figure 3.41: Target Compound Concentrations Expressed as %Remaining for Utility 
#8: High Level Spike 
3.2.2.2.2 Water 8: Low Level Spike 
The low level spike experiment was conducted in exactly the same fashion as the high 
level spike, except that a larger volume had to be used in order to accommodate the large 
sample volumes needed for SPE (Figure 3.38). 
As previously mentioned, this is water from a small surface water supply. The basic 
water quality parameters had a similar manner as they were in the high level spike study. The 
TOC was removed by about 28% through flocculation (Table 3.14, Figure 3.42).   
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Table 3.14: Basic Water Quality Parameters: Water #8: Low Level Spike 
Testing Parameter Raw Flocculated Filtered Finished  
pH 6.06 6.41  7.36  7.38  
Cl2 Residual (mg/L) N/A N/A N/A N/A 
TOC (mg/L) 2.67 1.90 2.35  2.30 
DOC (mg/L) 2.63  1.860  2.18  2.25  
Total N (mg/L) 0.18  0.21  0.21  0.21  
Dissolved N (mg/L) 0.18  0.19  0.19  0.20  
UV abs (/cm) 0.11  0.05  0.08  0.05  
SUVA (L/mg-m) 4.11  2.59  3.39  2.06  
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Figure 3.42: General Water Quality for Raw and Treated Water from Utility #8: Low 
Level Spike 
Figure 3.43 shows a decreasing trend of UV absorbance from raw water to finished 
water although there is a small increase in the filtered water.   
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Figure 3.43: Absorbance Spectra for Raw and Treated Water from Utility #8: Low 
Level Spike 
Target compound analysis (Figure 3.44) showed partial removal of ranitidine, 
ciprofloxacin and atorvastatin. Filtration across anthracite/sand resulted in some removals of 
naproxen and atorvastatin. This was presumably due to biological activity on the filters. Final 
chlorination seemed to have removed most of the compounds, such that only about 50% of 
the sulfamethoxazole, 20% of the ciprofloxacin and atorvastatin, but nearly all of the TCEP 
and DEET were remaining. 
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Table 3.15: Basic Water Quality Parameters: Water #12: High Level Spike 
Testing Parameter Raw Settled-GF/F Filtration Finished  
pH 6.51 6.84 5.33 5.93 
Turbidity (NTU) 0.20 0.05 0.05 0.25 
Iron (mg/L) 0.25 N/A 0.03 N/A 
Manganese (mg/L) 0.03 N/A 0.02 N/A 
Cl2 Residual (mg/L) N/A 0.14 0.04 N/A 
TOC (mg/L) 10.49 4.34 0.79 0.81 
DOC (mg/L) 9.78 4.50 0.66 0.56 
TN (mg/L) 0.44 N/A N/A N/A 
DN (mg/L) 0.43 N/A N/A N/A 
UV Abs @254 0.45 0.09 0.01 0.01 
SUVA 4.25 2.03 1.62 1.01 
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Figure 3.46: General Water Quality for Raw and Treated Water from Utility #12: High 
Level Spike 
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The absorbance spectra (Figure 3.47), reflect the high degree of NOM removal, first 
across coagulation/settling and then across GAC adsorption. 
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Figure 3.47: Absorbance Spectra for Raw and Treated Water from Utility #12: High 
Level Spike 
Disinfection byproduct analysis showed substantial formation of THMs with far 
lower formation of HAAs (Figure 3.48).  There was also a small amount of 
trichloropropanone (Figure 3.49). 
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Figure 3.48: Major DBP Species for Finished Water from Utility #12: High Level Spike 
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Figure 3.49: Minor DBP Species for Finished Water from Utility #12: High Level Spike 
Target compound analysis (Figure 3.50) showed near complete removal of ranitidine 
and ciprofloxacin after settling.  Filtration across GAC resulted in substantial removals of 
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atenolol, DEET, trimethoprim, sulfamethoxazole and naproxen.  This was presumably due to 
biological activity on the filters or the adsorption effect of the GAC media.  Final 
chlorination didn’t show strong effect on the target compound removal, possibly because 
there was very little left to remove. 
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Figure 3.50: Target Compound Concentrations Expressed as %Remaining for Utility 
#12: High Level Spike 
3.2.2.3.2 Water 12: Low Level Spike 
The low level spike experiment was conducted in exactly the same fashion as the high 
level spike, except that a larger volume had to be used in order to accommodate the large 
sample volumes needed for solid phase extraction (SPE) (Figure 3.45). 
As with the high level bench scale study, NOM (as represented by TOC and DOC) 
was well removed across treatment. Subsequent treatment significantly removed 99% 
organic carbon (Table 3.16, Figure 3.51).  
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Table 3.16: Basic Water Quality Parameters: Water #12: Low Level Spike 
Testing Parameter Raw Raw Filtered Settled-GF/F Filtration Finished  
pH 5.44 N/A 5.10 4.41 6.09 
Turbidity (NTU) 0.24 N/A 0.07 0.16 0.33 
Iron (mg/L) 0.22 N/A N/A 0.03 N/A 
Manganese (mg/L) 0.02 N/A N/A 0.03 N/A 
Cl2 Residual 
(mg/L) 
N/A N/A 0.10 0.11 N/A 
TOC (mg/L) 10.01 N/A 6.03 0.75 0.96 
DOC (mg/L) 10.23 N/A 5.81 0.67 0.77 
TN (mg/L) 0.43 0.47 N/A N/A N/A 
DN (mg/L) 0.44 0.42 N/A N/A N/A 
UV Abs @254 0.44 0.44 0.07 0.01 0.02 
SUVA 4.38 N/A 1.14 1.47 2.35 
 
Treatment
Raw Settled-GF/F Filtration Finished 
W
at
er
 Q
ua
lit
y 
V
al
ue
0
2
4
6
8
10
12
pH 
TOC (mg/L) 
DOC (mg/L) 
SUVA (L/mg-m)
 
Figure 3.51: General Water Quality for Raw and Treated Water from Utility #12: Low 
Level Spike 
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Figure 3.52 shows that there was a large amount of loss or destruction of UV 
absorbance. Again this parallels the high-level spike data. 
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Figure 3.52: Absorbance Spectra for Raw and Treated Water from Utility #12: Low 
Level Spike 
Disinfection byproduct analysis (Figure 3.53) showed substantial formation of THMs 
with far lower formation of HAAs.  In this case there was little formation of chloropicrin 
compared to the high level spike bench scale study. The minor DBP analysis was not shown 
in this report because there weren’t any minor DBPs formed during the experiment. 
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Figure 3.53: Major DBP Species for Finished Water from Utility #12: Low Level Spike 
3.2.2.4 Water 13 
Two 20 L samples were collected from this utility, each from the in-plant raw water 
tap.  The samples were collected at about 3:00 PM on Tuesday, February 3, 2009.   
Figure 3.54 shows the treatment sequence and doses used in the bench-scale tests 
with water #13. Three liters of the raw water was used for the high level spike study and 
eighteen liters of the raw water was used for the low level spike study considering the extra 
water needed for the solid phase extraction (SPE). 
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Table 3.17: Basic Water Quality Parameters: Water #13: High Level Spike 
Testing Parameter Raw Raw Filtered Settled-GF/C Filtered Finished  
pH 6.64 N/A 7.99 8.91 7.38 
Turbidity (NTU) 0.12 N/A 0.59 N/A 0.16 
Cl2 Residual 
(mg/L) 
N/A N/A N/A 0.17 N/A 
TOC (mg/L) 3.39 N/A 3.38 3.56 3.70 
DOC (mg/L) 3.46 4.33 3.54 3.65 3.61 
TN (mg/L) 0.17 N/A N/A N/A N/A 
DN (mg/L) 0.21 0.78 N/A N/A N/A 
UV Abs @254 0.10 0.10 0.20 0.12 0.12 
SUVA (L/mg-m) 3.08 N/A 5.84 3.39 3.33 
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Figure 3.55: General Water Quality for Raw and Treated Water from Utility #13: High 
Level Spike 
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The UV absorbance increased after settling and losses were noted in the subsequent 
treatment (Figure 3.56).  
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Figure 3.56: Absorbance Spectra for Raw and Treated Water from Utility #13: High 
Level Spike 
Disinfection byproduct analysis (Figure 3.57) showed moderate formation of THMs 
with lower formation of HAAs.  The preferential formation of THMs is expected for waters 
chlorinated at high pH as this is.  There was also an unusually high level of chloropicrin 
(Figure 3.58), which in this case could be attributed to reaction of chlorine with one or more 
of the target compounds. 
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Figure 3.57: Major DBP Species for Finished Water from Utility #13: High Level Spike 
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Figure 3.58: Minor DBP Species for Finished Water from Utility #13: High Level Spike 
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The recovery of aqueous standards was low and erratic.  For this reason, I prefer not 
to show the raw numbers for the target compound analysis at this time. 
3.2.2.4.2 Water 13: Low Level Spike 
The low level spike experiment was conducted in exactly the same fashion as the high 
level spike, except that a larger volume had to be used in order to accommodate the large 
sample volumes needed for solid phase extraction (SPE) (Figure 3.54). 
As with the high level spike bench scale study, the TOC level increased after the 
addition of the spike solution.  Subsequent treatment removed little or no organic carbon 
(Table 3.18, Figure 3.59).  Figure 3.60 shows that there was a small amount of loss or 
destruction of UV absorbance.  
Table 3.18: Basic Water Quality Parameters: Water #13: Low Level Spike 
Testing 
Parameter 
Raw Raw 
Filtered 
Settled-GF/C Filtered Finished  
pH 7.29 N/A 8.75 9.88 9.28 
Turbidity (NTU) 0.10 N/A 1.42 N/A 0.21 
Cl2 Residual 
(mg/L) 
N/A N/A N/A 0.14 N/A 
TOC (mg/L) 3.56 N/A 3.20 3.20 2.86 
DOC (mg/L) 3.30 4.49 2.78 3.00 2.83 
TN (mg/L) 0.18 N/A N/A N/A N/A 
DN (mg/L) 0.17 0.74 N/A N/A N/A 
UV Abs @254 0.11 0.12 0.30 0.07 0.07 
SUVA (L/mg-m) 3.07 N/A  9.51 2.19 2.51 
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Figure 3.59: General Water Quality for Raw and Treated Water from Utility #13: Low 
Level Spike 
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Figure 3.60: Absorbance Spectra for Raw and Treated Water from Utility #13: Low 
Level Spike 
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Disinfection byproduct analysis (Figure 3.61) showed substantial formation of THMs 
with far lower formation of HAAs.  As with the high-level spike, the preferential formation 
of THMs is expected for waters chlorinated at high pH as this is (Figure 3.62).  
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Figure 3.61: Major DBP Species for Finished Water from Utility #13: Low Level Spike 
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Figure 3.62: Minor DBP Species for Finished Water from Utility #13: Low Level Spike 
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The recovery of aqueous standards was low and erratic.  For this reason, I prefer not 
to show the raw numbers for the target compound analysis at this time. 
3.2.2.5 Water 14 
Two 20 L samples were collected from this utility, each from a different plant 
(designated A and B).  The samples were collected at about 5:00 -6:00 PM on Thursday, 
November 20, 2008.  Because of the enclosed nature of the greensand pressure filters, I was 
unable to obtain a sample of the active filtration media.  As a result, I was not able to fully 
simulate this process in the laboratory.  Instead I used standard filtration (glass fiber/fine) to 
achieve particle removal. 
Figure 3.63 shows the treatment sequence and doses used in the bench-scale tests 
with water #14A.  Three liters of the raw water was used for the high level spike study and 
ten liters of the raw water was used for the low level spike study considering the extra water 
needed for the solid phase extraction (SPE). 
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unexpected as manganese removal on greensand is far more effective than direct oxidation 
by chlorine and precipitation (Table 3.19, Figure 3.64). 
Table 3.19: Basic Water Quality Parameters: Water #14A: High Level Spike 
WQ Parameter Raw Filtered Aerated Finished  
pH 6.68 9.50 9.63 8.45 
Turbidity (NTU) 2.01 1.14 N/A 1.80 
Iron (mg/L) 0.41 0.00 N/A 0.00 
Manganese 
(mg/L) 
1.00 0.56 N/A 0.50 
Cl2 Residual 
(mg/L) 
N/A 1.64 1.630 N/A 
TOC (mg/L) 1.32 1.81 1.96 1.81 
DOC (mg/L)  N/A N/A  N/A  N/A  
Total N (mg/L) 1.48 N/A N/A N/A 
Dissolved N 
(mg/L) 
2.09 N/A N/A N/A 
UV abs (/cm) 0.03 0.04 0.04 0.03 
SUVA (L/mg-m) 2.49 2.25 1.81 1.69 
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Figure 3.64: General Water Quality for Raw and Treated Water from Utility #14A: 
High Level Spike 
The absorbance spectra are featureless (Figure 3.65), with higher intensities below 
220nm.  This may be enhanced by the presence of the manganese.  Small increases in UV 
absorbance in the vicinity of 254 nm may be attributed to some Fe/Mn colloid formation and 
resultant scattering of light, rather than true absorbance. 
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Figure 3.65: Absorbance Spectra for Raw and Treated Water from Utility #14A: High 
Level Spike 
Disinfection byproduct analysis (Figure 3.66) showed substantial formation of THMs 
with far lower formation of HAAs.  The preferential formation of THMs is expected for 
waters chlorinated at high pH as this is.  There was also an unusually high level of 
chloropicrin (Figure 3.67), which in this case was attributed to reaction of chlorine with one 
or more of the target compounds. 
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Figure 3.66: Major DBP Species for Finished Water from Utility #14A: High Level 
Spike 
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Figure 3.67: Minor DBP Species for Finished Water from Utility #14A: High Level 
Spike 
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Target compound analysis (Figure 3.68) showed near complete removal of all PPCP 
compounds except for DEET and TCEP.  While TCEP didn’t show a substantial drop, there 
was partial loss of DEET across final chlorination.  Very small amounts of naproxen and 
atorvastatin appeared following partial chemical treatment and filtration.  The Naproxen-Neg 
bar is a second check on this compound as quantified by ESI-negative, whereas the first was 
done using ESI-positive. 
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Figure 3.68: Target Compound Concentrations Expressed as %Remaining for Utility 
#14A: High Level Spike 
3.2.2.5.2 Water 14A: Low Level Spike 
The low level spike experiment was conducted in exactly the same fashion as the high 
level spike, except that a larger volume had to be used in order to accommodate the large 
sample volumes needed for solid phase extraction (SPE) (Figure 3.63). 
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As with most groundwaters, it has a low TOC level which increases after addition of 
the spike solution.  Subsequent treatment removed little or no organic carbon.  The SUVA 
decreased and increased, probably as a result of oxidation and some colloid formation (Table 
3.20, Figure 3.69). Figure 3.70 shows that there was a small amount of loss or destruction of 
UV absorbance.  
Table 3.20: Basic Water Quality Parameters: Water #14A: Low Level Spike 
Testing 
Parameter 
Raw Filtered Aerated Finished  
pH 6.58 9.53 9.64 9.00 
Turbidity (NTU) 1.650 0.160 N/A 0.235 
Iron (mg/L) 0.304 0.000 N/A 0.000 
Manganese 
(mg/L) 
0.770 0.688 N/A 0.451 
Cl2 Residual 
(mg/L) 
N/A 2.300 2.080 N/A 
TOC (mg/L) 1.361 1.195 1.123 1.195 
DOC (mg/L) 1.487 1.568 1.296 1.239 
Total N (mg/L) 1.483 N/A N/A N/A 
Dissolved N 
(mg/L) 
2.092 N/A N/A N/A 
UV abs (/cm) 0.052 0.045 0.040 0.050 
SUVA (L/mg-m) 3.829 3.284 3.384 4.207 
 
 
102 
 
Treatment
Raw Filtered Aerated Finished
W
at
er
 Q
ua
lit
y 
V
al
ue
0
2
4
6
8
10
pH 
TOC (mg/L) 
DOC (mg/L) 
SUVA (L/mg-m)
 
Figure 3.69: General Water Quality for Raw and Treated Water from Utility #14A: 
Low Level Spike 
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Figure 3.70: Absorbance Spectra for Raw and Treated Water from Utility #14A: Low 
Level Spike 
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Disinfection byproduct analysis (Figure 3.71) showed a substantial formation of 
THMs with a far lower formation of HAAs.  As with the high-level spike, the preferential 
formation of THMs is expected for waters chlorinated at high pH as this is.  In this case the 
HAAs were about the same as those produced in the high-level spike, but THMs were 
substantially lower.  This is probably attributed to extensive degradation of the target PPCPs 
with a relatively high yield of THMs.  Note that the aggregate PPCP concentration in the 
high-level experiments was in the low µM level, easily high enough to produce measureable 
THMs.  It’s also significant that the low-level spike failed to produce measureable levels of 
haloacetonitriles and chloropicrin.  Again, this is not surprising as the PPCPs contain 
substantial amounts of organic nitrogen that may easily degrade to amines capable of nitrile 
formation.  Some may undergo more extensive oxidation leading to formation of nitro groups. 
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Figure 3.71: Major DBP Species for Finished Water from Utility #14A: Low Level 
Spike 
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As with water #14A, this is a groundwater that is primarily treated for iron and 
manganese removal.  Fundamental water quality data (Table 3.21, Figure 3.73) show very 
similar patterns to those for water 14A.  One difference that may be important is the slightly 
lower raw water iron level for #14B.  Subsequent treatment removed little or no organic 
carbon (Figure 3.73), although iron was completely removed and manganese was once again 
removed by about 50%.   
Table 3.21: Basic Water Quality Parameters: Water #14B: High Level Spike 
WQ Parameter Raw Filtered Aerated Finished  
pH 6.71 9.85 10.01 9.18 
Turbidity (NTU) 0.82 0.83 N/A 1.37 
Iron (mg/L) 0.24 0.00 N/A 0.00 
Manganese (mg/L) 0.90 0.60 N/A 0.45 
Cl2 Residual 
(mg/L) 
N/A 1.81 1.67 N/A 
TOC (mg/L) 1.46 1.68 1.75 1.82 
Total N (mg/L) 0.18 N/A N/A N/A 
UV abs (/cm) 0.05 0.04 0.04 0.02 
SUVA (L/mg-m) 3.39 2.37 2.18 1.60 
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Figure 3.73: General Water Quality for Raw and Treated Water from Utility #14B: 
High Level Spike 
Figure 3.74 shows that there was a small amount of loss or destruction of UV 
absorbance. Perhaps in keeping with the lower iron levels, the far UV absorbance values 
were substantially lower, especially at the wavelengths below 220nm. 
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Figure 3.74: Absorbance Spectra for Raw and Treated Water from Utility #14B: High 
Level Spike 
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Disinfection byproduct analysis (Figure 3.75) showed somewhat higher formation of 
THMs and HAAs as compared to the same high-level spike tests with water #14A.  Perhaps 
for similar reasons, the minor DBP species showed higher formation as well (Figure 3.76).  
In particular the haloketones and halonitromethanes were substantially elevated.   
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Figure 3.75: Major DBP Species for Finished Water from Utility #14B: High Level 
Spike 
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Figure 3.76: Minor DBP Species for Finished Water from Utility #14B: High Level 
Spike 
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As with the 14A tests, target compound analysis (Figure 3.77) showed near complete 
removal of all PPCP compounds except for DEET and TCEP.  Again, TCEP didn’t show a 
substantial drop, whereas there was partial loss of DEET across final chlorination. 
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Figure 3.77: Target Compound Concentrations Expressed as %Remaining for Utility 
#14B: High Level Spike 
3.2.2.5.4 Water 14B: Low Level Spike 
The low level spike experiment was conducted in exactly the same fashion as the high 
level spike, except that a larger volume had to be used in order to accommodate the large 
sample volumes needed for solid phase extraction (SPE) (Figure 3.72). 
As previously mentioned, this is a groundwater that is primarily treated for iron and 
manganese removal.  As with most groundwaters, it has a low TOC level which increases 
after addition of the spike solution.  Subsequent treatment removed little or no organic 
carbon (Figure 3.78).   
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Table 3.22: Basic Water Quality Parameters: Water #14B: Low Level Spike 
Testing Parameter Raw Filtered Aerated Finished  
pH 7.02 9.38 9.43 9.12 
Turbidity (NTU) 0.578 0.076 N/A 0.335 
Iron (mg/L) 0.180 0.000 N/A 0.000 
Manganese (mg/L) 0.550 0.267 N/A 0.176 
Cl2 Residual (mg/L) N/A 0.330 0.300 N/A 
TOC (mg/L) 1.450 1.369 1.267 1.308 
DOC (mg/L) 1.401 1.364 1.295 1.267 
Total N (mg/L) 0.602 N/A N/A N/A 
Dissolved N (mg/L) 0.599 N/A N/A N/A 
UV abs (/cm) 0.051 0.039 0.040 0.033 
SUVA (L/mg-m) 3.535 2.800 2.929 2.511 
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Figure 3.78: General Water Quality for Raw and Treated Water from Utility #14B: 
Low Level Spike 
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Figure 3.79 shows that there was a small amount of loss or destruction of UV 
absorbance.  
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Figure 3.79: Absorbance Spectra for Raw and Treated Water from Utility #14B: Low 
Level Spike 
Disinfection byproduct analysis (Figure 3.80) showed substantial formation of THMs 
with far lower formation of HAAs.  As with the high-level spike, the preferential formation 
of THMs is expected for waters chlorinated at high pH as this is.  In this case the HAAs were 
about the same as those produced in the high-level spike, but THMs were substantially lower.  
This is probably attributed to extensive degradation of the target PPCPs with a relatively high 
yield of THMs. Note that the aggregate PPCP concentration in the high-level experiments 
were in the low µM level, easily high enough to produce measureable THMs.  It is also 
significant that the low-level spike failed to product measureable levels of haloacetonitriles 
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and chloropicrin.  Again, this is not surprising as the PPCPs contain substantial amounts of 
organic nitrogen that may easily degrade to amines capable of nitrile formation.  Some may 
undergo more extensive oxidation leading to formation of nitro groups, however, Ranitidine 
already presents a nitro group that may undergo halogenations on the alpha-carbon. 
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Figure 3.80: Major DBP Species for Finished Water from Utility #14B: Low Level 
Spike 
As with Water #14A, analysis of the target compounds in the low level spike 
experiments showed similar patterns of removal as compared to the high level experiments.   
Except for DEET and TCEP, extensive loss of all target compounds was noted.  However, 
the recovery of aqueous standards was again low and erratic.  For this reason, I considered 
these data to be qualitative and therefore prefer not to show the raw numbers at this time. 
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It also has the tendency to favor THMs over HAAs as is shown in the following pages. 
Substantial removal of the organic carbon was noted after settling. Subsequent treatment 
removed little organic carbon (Table 3.23, Figure 3.82).   
Table 3.23: Basic Water Quality Parameters: Water #16: High Level Spike 
Testing Parameter Raw Settled Filtered Finished  
pH 6.66 7.33 7.37 10.57 
Turbidity (NTU) 0.29 0.27 0.12 0.11 
Cl2 Residual (mg/L) N/A N/A 0.13 N/A 
TOC (mg/L) 5.48 2.42 2.49 2.77 
DOC (mg/L) 5.15 2.46 2.42 2.78 
Total N (mg/L) 0.19 N/A 0.20 0.18 
Dissolved N (mg/L) 0.20 N/A 0.19 0.20 
UV abs (/cm) 0.25 0.06 0.05 0.05 
SUVA (L/mg-m) 4.59 2.35 1.90 1.66 
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Figure 3.82: General Water Quality for Raw and Treated Water from Utility #16: High 
Level Spike 
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The absorbance spectra (Figure 3.83) show moderate destruction of UV absorbance 
after settling. Subsequent treatments had little effect on the NOM removal. However, the 
finished water showed very high intensity below 230 nm the reason of which is unclear. 
Wavelength (nm)
200 220 240 260 280 300 320 340
A
bs
or
ba
nc
e 
(c
m
-1
)
0.0
0.2
0.4
0.6
0.8
1.0
1.2
Raw 
Settled 
Filtered 
Finished 
Wavelength (nm)
240 245 250 255 260 265 270
Ab
so
rb
an
ce
 (c
m
-1
)
0.00
0.02
0.04
0.06
0.08
0.10
 
Figure 3.83: Absorbance Spectra for Raw and Treated Water from Utility 16: High 
Level Spike 
Disinfection byproduct analysis showed substantial formation of THMs with far 
lower formation of HAAs (Figure 3.84).  The preferential formation of THMs is expected for 
waters chlorinated at high pH as this is.  There was also an unusually high level of halo 
acetonitrile (Figure 3.85). 
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Figure 3.84: Major DBP Species for Finished Water from Utility #16: High Level Spike 
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Figure 3.85: Minor DBP Species for Finished Water from Utility #16: High Level Spike 
The recovery of aqueous standards was low and erratic.  For this reason, I prefer not 
to show the raw numbers for the target compound analysis at this time. 
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3.2.2.6.2 Water 16: Low Level Spike 
The low level spike experiment was conducted in exactly the same fashion as the high 
level spike, except that a larger volume had to be used in order to accommodate the large 
sample volumes needed for solid phase extraction (SPE) (Figure 3.81). 
Again, the pH was elevated to 10 after the addition of sodium hydroxide which will 
result in the preferential formation of THM over HAA that are mentioned in the following 
pages. Similar as the high level spike bench scale study, settling and filtration resulted in 
substantial removal of organic carbon (Table 3.24, Figure 3.86).                     
Table 3.24: Basic Water Quality Parameters: Water #16: Low Level Spike 
Testing Parameter Raw Settled Filtered Finished  
pH 6.95 6.81 6.78 10.54 
Turbidity (NTU) 0.33 0.28 0.23 0.20 
Cl2 Residual (mg/L) N/A N/A 0.11 N/A 
TOC (mg/L) 5.65 1.70 1.78 2.36 
DOC (mg/L) 5.52 1.67 1.58 2.21 
Total N (mg/L) 0.23 N/A 0.10 0.12 
Dissolved N (mg/L) 0.20 N/A 0.12 0.13 
UV abs (/cm) 0.25 0.02 0.04 0.06 
SUVA (L/mg-m) 4.44 1.37 2.41 2.48 
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Figure 3.86: General Water Quality for Raw and Treated Water from Utility #16: Low 
Level Spike 
The UV absorbance spectra showed a similar fashion as they were in the high level 
spike study (Figure 3.87). Again, substantial removal was noted after settling. The reason for 
the high intensity of the finished water below 220 nm is unclear.  
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Figure 3.87: Absorbance Spectra for Raw and Treated Water from Utility #16: Low 
Level Spike 
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Disinfection byproduct analysis (Figure 3.88) showed substantial formation of THMs 
with far lower formation of HAAs.  As with the high-level spike, the preferential formation 
of THMs is expected for waters chlorinated at high pH as this is.  In this case the HAAs and 
THMs were about the same as those produced in the high-level spike. Little formation of 
halo acetonitrile was noted in the low level spike study. 
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Figure 3.88: Major DBP Species for Finished Water from Utility #16: Low Level Spike 
The recovery of aqueous standards was low and erratic.  For this reason, I prefer not 
to show the raw numbers for the target compound analysis at this time. 
3.2.3 Utilities with oxidation and filtration 
3.2.3.1 Water 7 
Utility #7 uses a surface water supply from a well-protected, forested watershed. 
There is little opportunity for anthropogenic pollutants to enter this system. The raw water is 
low in alkalinity and hardness. 
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Table 3.25: Basic Water Quality Parameters: Water #7: High Level Spike 
Testing Parameter Raw Raw Filtered Ozonated  Chlorinated  Finished  
pH 5.88 N/A 5.71 7.85 7.24 
Turbidity (NTU) 0.20 N/A 0.16 0.14 0.09 
Cl2 Residual (mg/L) N/A N/A N/A 0.19 2.12 
Ozone Residual 
(mg/L) 
N/A N/A 0.03 N/A N/A 
TOC (mg/L) 2.63 N/A 2.94 2.76 2.65 
DOC (mg/L) 2.78 3.64 2.80 2.81 2.58 
TN (mg/L) 0.22 N/A N/A N/A N/A 
DN (mg/L) 0.31 0.42 N/A N/A N/A 
UV Abs @254 0.07 N/A 0.02 0.02 0.02 
SUVA (L/mg-m) 2.73 N/A  0.54 0.61 0.72 
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Figure 3.90: General Water Quality for Raw and Treated Water from Utility #7: High 
Level Spike 
The absorbance spectra are low in magnitude and featureless (Figure 3.91). 
Substantial destruction of UV absorbance was noted following ozonation. A small amount of 
increase in the absorbance was noted in the finished water which is possibly the result of 
light scattering. 
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Figure 3.91: Absorbance Spectra for Raw and Treated Water from Utility #7: High 
Level Spike 
 
Disinfection byproduct analysis (Figure 3.92) showed moderate formation of THMs 
with much lower formation of HAAs. There was also some haloketone and haloacetonitrile 
formation (Figure 3.93). 
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Figure 3.92: Major DBP Species for Finished Water from Utility #7: High Level Spike 
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Figure 3.93: Minor DBP Species for Finished Water from Utility #7: High Level Spike 
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3.2.3.1.2 Water 7: Low Level Spike 
The low level spike experiment was conducted in exactly the same fashion as the high 
level spike, except that a larger volume had to be used in order to accommodate the large 
sample volumes needed for SPE (Figure 3.89). 
Similar to the high level spike test, the pH elevated from 6.46 to 8.33 in the low level 
spike test. Subsequent treatment removed little or no organic carbon. The SUVA decreased 
throughout the treatment due to the rather substantial ozone-induced bleaching of the NOM 
(Table 3.26, Figure 3.94).   
Table 3.26: Basic Water Quality Parameters: Water #7: Low Level Spike 
Testing 
Parameter 
Raw Raw 
Filtered 
Ozonated  Chlorinated  Finished 
pH 6.46 N/A 6.06 8.93 8.33 
Turbidity 
(NTU) 
0.18 N/A 0.13 0.17 0.18 
Cl2 Residual 
(mg/L) 
N/A N/A N/A 0.00 2.46 
Ozone Residual 
(mg/L) 
N/A N/A 0.01 N/A N/A 
TOC (mg/L) 2.74 N/A 2.47 2.46 2.46 
DOC (mg/L) 2.67 3.09 2.45 2.34 2.35 
TN (mg/L) 0.236 N/A N/A N/A N/A 
DN (mg/L) 0.24 0.27 N/A N/A N/A 
UV Abs @254 0.08 N/A 0.03 0.02 0.03 
SUVA (L/mg-m) 2.79 N/A  1.09 0.99 1.02 
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Figure 3.94: General Water Quality for Raw and Treated Water from Utility #7: Low 
Level Spike 
Figure 3.95 shows that there was a destruction of UV absorbance. It showed a similar 
trend as in the high level spike study. 
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Figure 3.95: Absorbance Spectra for Raw and Treated Water from Utility #7: Low 
Level Spike 
Disinfection byproduct analysis (Figure 3.96, Figure 3.97) showed moderate 
formation of THMs with far lower formation of HAAs.  As with the high-level spike, the 
preferential formation of THMs is probably an indication of autochthonous sources of NOM 
for this utility. In this case the major and minor DBPs were about the same as those produced 
in the high level spike. 
127 
 
Major DBP Species
THMs MHAA DHAA THAA
C
on
ce
nt
ra
tio
n 
( g
/L
)
0
10
20
30
40
50
CHCl3 
CHCl2Br 
CHClBr2 
CHBr3 
MCAA 
MBAA 
DCAA 
BCAA 
DBAA 
TCAA 
BDCAA 
CDBAA 
 
Figure 3.96: Major DBP Species for Finished Water from Utility #7: Low Level Spike 
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Figure 3.97: Minor DBP Species for Finished Water from Utility #7: Low Level Spike 
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3.2.3.2 Water 9 
Seven raw water samples (two 20-L; five 1-L) were collected from utility #9. The 
large samples were collected in polyethylene carboys, and the smaller ones were in 
borosilicate glass with teflon-lined caps. The samples were collected about 10 AM on Friday, 
June 12, 2009. All samples came from the plant influent. This plant uses mostly surface 
water.  
Figure 3.98 shows the treatment sequence and doses used in the bench-scale tests 
with water #9. Chlorine dioxide was used for pre-oxidation of this surface water. 3L of the 
raw water was used for the high level spike study and eighteen liters of the raw water was 
used for the low level spike study considering the extra water needed for the solid phase 
extraction (SPE). 
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Table 3.27: Basic Water Quality Parameters: Water #9: High Level Spike 
Testing Parameter Raw Filtered Finished  
pH 6.75 7.25 8.10 
Turbidity 0.14 0.09 0.13 
Cl2 Residual (mg/L) N/A 0.46 N/A 
TOC (mg/L) 2.80 2.64 2.61 
DOC (mg/L) 2.63 2.61 2.66 
Total N (mg/L) 0.43 0.44 0.41 
Dissolved N (mg/L) 0.50 0.46 0.42 
UV abs (/cm) 0.07 0.05 0.04 
SUVA (L/mg-m) 2.33 1.87 1.64 
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Figure 3.99: General Water Quality for Raw and Treated Water from Utility #9: High 
Level Spike 
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The absorbance spectra (Figure 3.100) showed decreasing UV absorbance from raw 
water to finished water.  Extensive pre-oxidation with chlorine dioxide helped to reduce 
absorbance in the UV range by nearly 34%.  Additional absorbance destruction was noted 
across GAC filtration. 
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Figure 3.100: Absorbance Spectra for Raw and Treated Water from Utility #9: High 
Level Spike 
Target compound analysis (Figure 3.101) showed near complete removal of ranitidine, 
sulfamethoxazole, trimethoprim and naproxen by pre-oxidation. Filtration resulted in 
substantial removals of ciprofloxacin. This was presumably due to biological activity on the 
filters. Final chlorination seemed to have resulted in additional losses of atenolol. Nearly 100% 
of DEET and TCEP persisted through the treatment process. 
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Figure 3.101: Target Compound Concentrations Expressed as %Remaining for Utility 
#9: High Level Spike 
3.2.3.2.2 Water 9: Low Level Spike 
The low level spike experiment was conducted in exactly the same fashion as the high 
level spike (Figure 3.98), except that a larger volume had to be used in order to accommodate 
the large sample volumes needed for solid phase extraction (SPE). 
As previously mentioned in chapter 2, this is water from a small surface water supply. 
The pH was elevated by the calcium hydroxide from 6.75 to 8.20. It has a moderate TOC 
level which decreased by about 15% across filtration (Table 3.28, Figure 3.102).  Figure 
3.103 shows the absorbance spectra have trends that are similar to those for the high level 
tests.  
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Table 3.28: Basic Water Quality Parameters: Water #9: Low Level Spike 
Testing Parameter Raw Filtered Finished 
pH 6.75 7.90 8.20 
Turbidity 0.14 0.14 0.13 
Cl2 Residual (mg/L) N/A 0.24 N/A 
TOC (mg/L) 2.80 2.38 2.27 
DOC (mg/L) 2.63 2.39 2.32 
Total N (mg/L) 0.43 0.38 0.37 
Dissolved N (mg/L) 0.50 0.39 0.35 
UV abs (/cm) 0.07 0.04 0.04 
SUVA (L/mg-m) 2.33 1.59 1.53 
 
Treatment
Raw Filtered Finished 
W
at
er
 Q
ua
lit
y 
V
al
ue
0
2
4
6
8
10
pH 
TOC (mg/L) 
DOC (mg/L) 
SUVA (L/mg-m) 
 
Figure 3.102: General Water Quality for Raw and Treated Water from Utility #9: Low 
Level Spike 
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Figure 3.103: Absorbance Spectra for Raw and Treated Water from Utility #9: Low 
Level Spike 
Target compound analysis (Figure 3.104) showed near complete removal of ranitidine 
and estrone by pre-oxidation and settling. Filtration across GAC resulted in substantial 
removals of ciprofloxacin, sulfamethoxazole and trimethoprim. This was presumably due to 
biological activity on the filters. Final chlorination seemed to have resulted in additional 
losses, such that only about 30% of naproxen, 15% of ranitidine and 10% of atorvastatin was 
remaining. 
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Figure 3.104: Target Compound Concentrations Expressed as %Remaining for Utility 
#9: Low Level Spike 
3.2.3.3 Water 10 
Two 20 L samples were collected from an inside tap at this utility. At the same time 
three 2L samples were collected in glass from the same inside tap. The samples were 
collected at about 2:00 PM on Monday, April 13, 2009. 
Figure 3.105 shows the treatment sequence and doses used in the bench-scale tests 
with water #10. Utility 10 uses a suburban lake as its source. It is in a restricted zone where 
there are no recreational uses. At the time of sampling, the lake was covered by a layer of ice. 
Three liters of the raw water was used for the high level spike study and eighteen liters of the 
raw water was used for the low level spike study considering the extra water needed for the 
solid phase extraction (SPE). 
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Table 3.29: Basic Water Quality Parameters: Water #10: High Level Spike 
Testing 
Parameter Raw Settled Ozonated Filtered Chlorinated  Finished 
pH 6.89 7.30 7.44 6.99 7.44 6.90 
Turbidity 
(NTU) 
0.22 0.20 0.20 0.79 0.63 0.61 
Iron (mg/L) N/A N/A N/A 0.02 N/A N/A 
Manganese 
(mg/L) 
N/A N/A N/A 0.01 N/A N/A 
Ozone 
Residual 
(mg/mL) 
N/A N/A N/A N/A N/A N/A 
Cl2 Residual 
(mg/L) 
N/A 0.00 N/A 0.00 1.87 N/A 
TOC (mg/L) 4.77 4.03 3.97 3.98 N/A 4.17 
DOC (mg/L) 4.88 3.66 3.75 3.95 3.93 3.84 
Total N (mg/L) 0.37 N/A N/A 0.59 N/A 0.89 
Dissolved N 
(mg/L) 
0.35 N/A N/A 0.54 N/A 0.71 
UV abs (/cm) 0.19 0.12 0.09 0.13 0.13 0.12 
SUVA (L/mg-
m) 
3.96 2.85 2.35 3.36 3.29 2.77 
 
138 
 
Treatment
Raw Setteled Ozonated Filtered Chlorinated Finished 
W
at
er
 Q
ua
lit
y 
V
al
ue
0
2
4
6
8
10
pH 
TOC (mg/L) 
DOC (mg/L) 
SUVA (L/mg-m) 
 
Figure 3.106:  General Water Quality for Raw and Treated Water from Utility #10: 
High Level Spike 
Figure 3.107 shows that there was a substantial decrease in UV absorbance through 
coagulation and settling, but more complex behavior further downstream of settling. The 
absorbance spectra showed the filtered, chlorinated and finished water having relatively high 
intensities below wavelength 210 nm. 
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Figure 3.107: Absorbance Spectra for Raw and Treated Water from Utility #10: High 
Level Spike 
Disinfection byproduct analysis (Figure 3.108) showed moderate formation of THMs 
with far lower formation of HAAs and small amounts of haloketones (Figure 3.109).   
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Figure 3.108: Major DBP Species for Finished Water from Utility #10: High Level 
Spike 
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Figure 3.109: Minor DBP Species for Finished Water from Utility #10: High Level 
Spike 
Target compound analysis (Figure 3.110) showed that after settling, 80% of the 
ciprofloxacin was removed. Partial loss of atenolol, ranitidine, trimethoprim, 
sulfamethoxazole was observed during ozonation. Filtration across GAC was able to remove 
most of the compounds except DEET, TCEP and naproxen. DEET and TCEP were resistant 
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to chlorination and chloramination. Nearly 50% of the DEET and TCEP remained in the 
finished water. 
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Figure 3.110: Target Compound Concentrations Expressed as %Remaining for Utility 
#10: High Level Spike 
3.2.3.3.2 Water 10: Low Level Spike 
As previously mentioned, the water comes from a suburban lake with no recreation 
use nearby. The low level spike experiment was conducted in exactly the same fashion as the 
high level spike, except that a larger volume had to be used in order to accommodate the 
large sample volumes needed for solid phase extraction (SPE) (Figure 3.105). 
The pH stayed within the range of 6.3 to 7.5 throughout the treatment.  The data in 
Figure 3.111 and Table 3.30 seem to indicate that flocculation and settling resulted in about 
36% NOM removal which is nearly identical to the spike-corrected value for the high-level 
tests. However, once again the TOC level appeared to increase across filtration. This is 
reflected in the UV absorbance (Figure 3.112). 
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Table 3.30: Basic Water Quality Parameters: Water #10: Low Level Spike 
Testing Parameter Raw Settled Ozonated Filtered Chlorinated  Finished  
pH 6.89 7.30 6.32 7.00 7.54 7.32 
Turbidity (NTU) 0.22 0.20 0.38 1.48 1.08 1.10 
Iron (mg/L) N/A N/A N/A 0.01 N/A N/A 
Manganese (mg/L) N/A N/A N/A 0.15 N/A N/A 
Ozone Residual 
(mg/mL) 
N/A N/A N/A N/A N/A N/A 
Cl2 Residual (mg/L) N/A 0.00 N/A 0.00 1.70 N/A 
TOC (mg/L) 4.77 3.13 2.89 4.10 N/A 3.80 
DOC (mg/L) 4.88 3.09 2.75 3.62 3.47 3.55 
Total N (mg/L) 0.37 N/A N/A 0.39 N/A 0.75 
Dissolved N (mg/L) 0.35 N/A N/A 0.32 N/A 0.69 
UV abs (/cm) 0.19 0.08 0.07 0.14 0.12 0.09 
SUVA (L/mg-m) 3.96 2.48 N/A 3.33 3.56 2.38 
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Figure 3.111: General Water Quality for Raw and Treated Water from Utility #10: 
Low Level Spike 
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Figure 3.112: Absorbance Spectra for Raw and Treated Water from Utility #10: Low 
Level Spike 
Disinfection byproduct analysis showed moderate formation of THMs with a far 
lower formation of HAAs (Figure 3.113), along with some formation of haloketones and 
haloacetonitriles (Figure 3.114). 
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Figure 3.113: Major DBP Species for Finished Water from Utility #10: Low Level Spike 
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Figure 3.114: Minor DBP Species for Finished Water from Utility #10: Low Level Spike 
The target compound analysis (Figure 3.115) showed nearly complete removal of 
atenolol, ranitidine, ciprofloxacin and atorvastatin throughout the treatment process. Similar 
to other utilities, DEET showed a strong resistance to removal. Around 60% of 
sulfamethoxazole, trimethoprim and naproxen remained in the finished water. 
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Figure 3.115: Target Compound Concentrations Expressed as %Remaining for Utility 
#10: Low Level Spike 
3.2.3.4 Water 11 
Five raw water samples (three 20-L; two 2-L) were collected from utility #11. The 
large samples were collected in polyethylene carboys, and the smaller ones were in 
borosilicate glass with Teflon-lined caps. In addition, one sample was transferred and 
returned as a travel/field blank. The samples were collected at about 11 AM on Tuesday, 
November 24, 2009. All samples came from well #3A. 
Figure 3.116 shows the treatment sequence and doses used in the bench-scale tests 
with water #11. Three liters of the raw water was used for the high level spike study and ten 
liters of the raw water was used for the low level spike study considering the extra water 
needed for the solid phase extraction (SPE). 
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Table 3.31: Basic Water Quality Parameters: Water #11: High Level Spike 
Testing Parameter Raw Chlorinated Finished  
pH 6.59 N/A 11.5 
Turbidity 0.11 N/A N/A 
Cl2 Residual (mg/L) N/A 2.33 N/A 
TOC (mg/L) 0.67 N/A 1.41 
DOC (mg/L) 0.57 N/A 1.42 
Total N (mg/L) 6.24 N/A N/A 
Dissolved N (mg/L) 6.20 N/A N/A 
UV abs (/cm) 0.01 N/A 0.06 
SUVA (L/mg-m) 0.83 N/A 4.50 
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Figure 3.117: General Water Quality for Raw and Treated Water from Utility #11: 
High Level Spike 
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The absorbance spectra are featureless (Figure 3.118).  Small increases in UV 
absorbance across all wavelengths for the finished water may be attributed to some colloid 
formation and resultant scattering of light, rather than true absorbance. 
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Figure 3.118: Absorbance Spectra for Raw and Treated Water from Utility #11: High 
Level Spike 
Target compound analysis (Figure 3.119) shows that trimethoprim and ranitidine 
were completely removed after the treatment. Ciprofloxacin was removed by 80% and 
naproxen was removed by 60%. 
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Figure 3.119: Target Compound Concentrations Expressed as %Remaining for Utility 
#11: High Level Spike 
 
3.2.3.4.2 Water 11: Low Level Spike 
The low level spike experiment was conducted in exactly the same fashion as the high 
level spike, except that a larger volume had to be used in order to accommodate the large 
sample volumes needed for solid phase extraction (SPE) (Figure 3.116). 
Different from the high level spike study, TOC and DOC Level stayed constant 
throughout the treatment in the low level spike study.  Subsequent treatment removed little 
organic carbon (Figure 3.120).  
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Table 3.32: Basic Water Quality Parameters: Water #11: Low Level Spike 
Testing Parameter Raw Chlorinated Finished  
pH 6.59 N/A 10 
Turbidity 0.11 N/A N/A 
Cl2 Residual (mg/L) N/A 1.10 N/A 
TOC (mg/L) 0.67 N/A 0.73 
DOC (mg/L) 0.57 N/A 0.68 
Total N (mg/L) 6.24 N/A N/A 
Dissolved N (mg/L) 6.20 N/A N/A 
UV abs (/cm) 0.03 N/A 0.01 
SUVA (L/mg-m) 4.35 N/A 1.84 
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Figure 3.120: General Water Quality for Raw and Treated Water from Utility #11: 
Low Level Spike 
Figure 3.121 shows that there was a small amount of increase of UV absorbance in 
the finished water, possibly from elevated pH and light scattering from metal colloid 
formation. 
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Figure 3.121:  Absorbance Spectra for Raw and Treated Water from Utility #11: Low 
Level Spike 
As with the other bench scale treatment studies, DEET remained resistant to the 
treatment. In contrast to the high level spike study, naproxen was completely removed after 
chlorination (Figure 3.122). 
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Figure 3.122: Target Compound Concentrations Expressed as %Remaining for Utility 
#11: Low Level Spike 
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3.2.3.5 Water 15  
Utility #15 uses an impacted river source with a long history of municipal, industrial 
and diffuse inputs. Nine raw water samples (six 20-L; three 2-L) were collected from utility 
#15 as listed below. The large samples were collected in polyethylene carboys, and the 
smaller ones were in borosilicate glass with Teflon-lined caps. In addition, one sample was 
transferred and returned as a travel/field blank. The samples were collected at about 10:30 
AM on Tuesday, September 15, 2009. 
Figure 3.123 shows the treatment sequence and doses used in the bench-scale tests 
with water #15.  The water came from a surface water supply. Three liters of the raw water 
was used for the high level spike study and eighteen liters of the raw water was used for the 
low level spike study considering the extra water needed for the solid phase extraction (SPE). 
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Table 3.33: Basic Water Quality Parameters: Water #15: High Level Spike 
Testing Parameter Raw Clarified Ozonated Filtered Chlorinated  Finished  
pH 7.65 7.22 6.81 7.19 7.44 7.24  
Turbidity (NTU) 1.50 0.15 0.21 0.36 0.44 0.35 
Cl2 Residual 
(mg/L) 
N/A N/A N/A 0.09  0.00  N/A 
Ozone Residual 
(mg/L) 
N/A N/A N/A N/A N/A N/A 
TOC (mg/L) 4.04  2.72 2.62  2.32  2.53 2.29  
DOC (mg/L) 4.01 2.77 2.57 2.23  2.54  2.23  
Total N (mg/L) 2.64  0.75 0.74  0.75  0.65  0.77  
Dissolved N (mg/L) 0.76 0.72 0.69  0.75 0.63  0.75 
UV abs (/cm) 0.16 0.07  0.06 0.06 0.05  0.05  
SUVA (L/mg-m) 4.07 2.39  2.36 2.65  2.09  2.21  
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Figure 3.124: General Water Quality for Raw and Treated Water from Utility #15: 
High Level Spike 
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Substantial destruction of UV absorbance was noted through clarification. Subsequent 
treatment resulted in a small amount of loss or destruction of UV absorbance (Figure 3.125).  
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Figure 3.125: Absorbance Spectra for Raw and Treated Water from Utility #15: High 
Level Spike 
Disinfection byproduct analysis showed substantial formation of THMs with a lower 
formation of HAAs (Figure 3.126). More CHCl2Br was form in the finishes water. The 
reason could be due to the higher concentration of bromide in the raw water.  
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Figure 3.126: Major DBP Species for Finished Water from Utility #15: High Level 
Spike 
The recovery of aqueous standards was low and erratic.  For this reason, I prefer not 
to show the raw numbers for the target compound analysis at this time. 
3.2.3.5.2 Water 15: Low Level Spike 
The low level spike experiment was conducted in exactly the same fashion as the high 
level spike, except that a larger volume had to be used in order to accommodate the large 
sample volumes needed for solid phase extraction (SPE) (Figure 3.123). 
As with the high level spike study, the pH stayed constant throughout the treatment 
(Table 3.34, Figure 3.127).  The TOC and DOC did show very modest decreases across 
treatment, as expected.  The SUVA decreased and increased, probably as a result of 
oxidation and some colloid formation. 
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Table 3.34: Basic Water Quality Parameters: Water #15: Low Level Spike 
Testing 
Parameter Raw Clarified Ozonated Filtered Chlorinated  Finished 
pH 7.65  6.98  6.97 7.38  7.43  7.47  
Turbidity 
(NTU) 
1.50  0.12 0.13 0.31  0.31  0.66  
Cl2 Residual 
(mg/L) 
N/A N/A N/A 0.17  0.00  N/A 
Ozone 
Residual 
(mg/L) 
N/A N/A N/A N/A N/A N/A 
TOC (mg/L) 4.04  2.22  2.17 1.86  1.90  1.79  
DOC (mg/L) 4.01  2.28  2.18  1.77  1.83  1.76  
Total N 
(mg/L) 
2.64  0.69  0.69  0.66  0.68  0.57  
Dissolved N 
(mg/L) 
0.76  0.68 0.73 0.66  0.65 0.63  
UV abs 
(/cm) 
0.16  0.05  0.03  0.03  0.03  0.04  
SUVA 
(L/mg-m) 
4.07  2.12  1.28  1.39  1.39  2.03  
 
Substantial destruction of UV absorbance was noted after ozonation. There was a 
small increase in the finished water which could be a result of light scattering (Figure 3.128). 
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Figure 3.127: General Water Quality for Raw and Treated Water from Utility #15: 
Low Level Spike 
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Figure 3.128: Absorbance Spectra for Raw and Treated Water from Utility #15: Low 
Level Spike 
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Disinfection byproduct analysis (Figure 3.129, Figure 3.130) showed substantial 
formation of THMs with far lower formation of HAAs.  As with the high-level spike, the 
preferential formation of THMs is expected for waters chlorinated at high pH as this is.  The 
preferential formation of CHCl2Br could be due to the higher concentration of bromide in the 
water. In this case the HAAs and THMs were about the same as those produced in the high-
level spike except that more DCAN, TCP and DP were formed in the low level spike study.  
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Figure 3.129: Major DBP Species for Finished Water from Utility #15: Low Level Spike 
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Figure 3.130: Minor DBP Species for Finished Water from Utility #15: Low Level Spike 
The recovery of aqueous standards was low and erratic.  For this reason, I prefer not 
to show the raw numbers for the target compound analysis at this time. 
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CHAPTER 4 SUMMARY AND CONCLUSION 
This chapter summarizes the results from chapter 3 by comparing the effectiveness of 
different treatment techniques between different compounds for both the high level spike 
study and the low level spike study.  
4.1 Summary  
4.1.1 Estrone 
Estrone is a natural ovarian estrogenic hormone that is available as an aqueous 
mixture of water insoluble estrone and water soluble estrone potassium sulfate. 
The removal efficiency for different treatment techniques for estrone is summarized 
in Figure 4.1 (expressed as % removal). Final chlorination refers to treatment sequence 
where chlorination is combined with other treatment techniques while chlorination refers to 
when chlorination is the only treatment used. HL in the plot represents the high level spike 
study and LL represents the low level spike study. The treatment removal percentage was 
calculated based on the avenge target compound removal from different utilities. 
Considering the low recovery of the aqueous standard in the high level spike study, 
only data from chlorination are shown in this plot. Base on the study from Deborde and the 
co-workers, steroidal estrogens are very reactive with chlorine (Deborde et al., 2008). For 
both the high level spike study and the low level spike study, chlorination has a similar 
removal rate for estrone; about 40%. Chloramination and chlorination are the most effective 
in the low level spike study, nearly all of estrone was removed. Coagulation, filtration and 
ozonation had similar removal efficiency which is around 38% of estrone. In contrast, some 
studies show that ozonation is able to remove 60% to 80% of estrone (Choi et al., 2006; 
Westerhoff et al., 2005). The reason for this difference could be the ozone dosage that was 
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used in the bench-scale stimulation. Raw water chemistry is another possible cause for this 
difference. 
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Figure 4.1: Treatment removal efficiency for estrone 
4.1.2 Atorvastatin 
    Atorvastatin is a drug used for blood cholesterol.  Atorvastatin was first synthesized in 
1985. It is likely to cause harm to fetal development because of the importance of cholesterol 
and various products in the cholesterol biosynthesis pathway for fetal development, including 
steroid synthesis and cell membrane production. 
The treatment removal efficiency for atorvastatin is summarized in Figure 4.2 and it 
is expressed as % removal. Ozonation and final chlorination are shown to be the most 
effective technique to remove atorvastatin. Both of the techniques removed nearly 100% of 
atorvastatin during the treatment process. Filtration removed 65% of atorvastatin in both the 
high level spike study and the low level spike study. Chloramination removed around 90% of 
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the atorvastatin. Coagulation and chloramination are more effective when the concentration 
of atorvastatin is higher. 
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Figure 4.2: Treatment removal efficiency for atorvastatin 
4.1.3 Naproxen 
Naproxen is a non-steroidal inflammatory drug that is used for pain killing, 
inflammation a fever due to a wide range of maladies.  
The removal efficiency of different treatment techniques for naproxen is summarized 
in Figure 4.3 (expressed as % removal). Similar to the removal of the other compounds 
mentioned before, oxidation processes (ozonation, chloramination and chlorination) were 
more effective at high naproxen concentration. Huber, Westerhoff and their co-workers also 
indicated that high level of ozone can remove Naproxen to a similar extent as chlorine does 
(Huber et al., 2005a; Westerhoff et al., 2005). Filtration achieved higher removal efficiency 
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in the high level spike study. Coagulation removed around 25% of Naproxen. This result is 
similar to Boyd and his coworkers’ study that naproxen was not removed by conventional 
treatment (coagulation, flocculation and sedimentation) (Boyd et al., 2003). 
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Figure 4.3: Treatment removal efficiency for naproxen 
4.1.4 Sulfamethoxazole 
Sulfamethoxazole is a sulfonamide bacteriostatic antibiotic that is commonly used to 
treat urinary tract infections. In addition, it can be used as an alternative to amoxicillin-based 
antibiotics to treat sinusitis. It can also be used to treat toxoplasmosis. 
The treatment removal efficiency for sulfamethoxazole is summarized in Figure 4.4 
and it is expressed as % removal. As the aqueous standard recovery is low for the low level 
spike study, the plot only shows the result of chlorination, ozonation and filtration. 
Chlorination was highly effective in removing sulfamethoxazole. More sulfamethoxazole 
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was removed through chlorination in the low level spike study. Snyder and co-workers have 
found that at pH 5.5, the removal rate during chlorination was mostly equal to or higher than 
those at ambient pH (Snyder et al., 2007). Ozonation was not as effective as filtration and 
final chlorination but was able to remove nearly 70% of the sulfamethoxazole. Similar to 
other highly soluble PPCPs, sulfamethoxazole is difficult to be removed through coagulation. 
Less than 40% of the sulfamethoxazole was removed. 
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Figure 4.4: Treatment removal efficiency for sulfamethoxazole 
4.1.5 Trimethoprim 
Trimethoprim is a bacteriostatic antibiotic mainly used in the prophylaxis and 
treatment of urinary tract infections. 
The removal efficiency for trimethoprim under both the high level spike and the low 
level spike study is summarized in Figure 4.5. Similar to the finding by Adam and co-
workers (2002), chlorination and ozonation removed more than 50% of the trimethoprim at 
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typical dosages. Another study noted that moderate or high ozone or chlorine dosage can 
completely remove trimethoprim (Westerhoff et al., 2005). Filtration and ozonation worked 
better under higher trimethoprim dosage while chloramination and final chlorination work 
better for lower trimethoprim concentration. The reaction rate of ozone with trimethoprim 
has been found to be moderately pH dependent due to the proximity of the second pKa to 
neutrality. Coagulation can only remove less than 20% of trimethoprim. 
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Figure 4.5: Treatment removal efficiency for trimethoprim 
 
4.1.6 Atenolol 
Atenolol is a drug that is used primarily in cardiovascular diseases. It is widely found 
in the aquatic environment because nearly 50% to 90% of ingested atenolol is excreted in its 
unconjugated form (Mompelat et al., 2009). 
The removal efficiency of different treatment techniques for atenolol is summarized 
in Figure 4.6 (expressed as % removal). Again, chloramination and chlorination achieved 
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highest removal efficiency for atenolol. Previous studies noted that atenolol reacts with 
chlorine rapidly while producing stable daughter-products that could revert back to the native 
atenolol with the existence of a reducing agent (Deborde et al., 2008; Benotti et al., 2009). 
This could result in less removal of atenolol through chlorination. Different from the effects 
on other compounds (sulfamethoxazole, naproxen and DEET), filtration removed most of the 
atenolol for both the high level spike study and the low level spike study. Coagulation 
removed around 30% of atenolol in both study. Ozonation was more effective than 
coagulation and removed 60% of the atenolol.  
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Figure 4.6: Treatment removal efficiency for atenolol 
4.1.7 Ranitidine 
Ranitidine is a histamine H2-receptor antagonist that inhibits stomach acid production. 
It is commonly used in treatment of peptic ulcer disease and gastroesophageal reflux disease. 
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Ranitidine is also used alongside fexofenadine and other antihistamines for the treatment of 
skin conditions such as hives.  
The removal efficiency for ranitidine during both the high level and the low level 
study is summarized in Figure 4.7. Most of the treatment techniques removed more than 50% 
of ranitidine in both the high level spike study and the low level spike study. Final 
chlorination and ozonation are shown to be the most effective method and were able to 
remove more than 90% of ranitidine. 
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Figure 4.7: Treatment removal efficiency for ranitidine 
4.1.8 Ciprofloxacin 
Ciprofloxacin is a synthetic chemotherapeutic antibiotic that kills bacteria by 
interfering with the enzymes that cause DNA to rewind after being copied, which stops 
synthesis of DNA and of protein. 
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The treatment removal efficiency for ciprofloxacin is summarized in Figure 4.8 and it 
is expressed as % removal. Nearly 100% of ciprofloxacin was removed through chlorination. 
In another study with drinking water and wastewater, the removal of ciprofloxacin ranged 
from 20% to 90% using 2mg/L chlorine dose (Dodd et al., 2005). Chloramination removed 
90% of the ciprofloxacin in the high level spike study. However, only 17% of the 
ciprofloxacin was removed by chloramination in the low level spike study. Coagulation and 
chlorination achieved similar removal rate in both the high level spike study and the low 
level spike study. Filtration removed 64% of the ciprofloxacin in the high level spike study. 
Again, ozonation showed a strong ability in removing ciprofloxacin (60% to 90%). The 
removal of ciprofloxacin through ozonation has been found to be highly pH dependent (Dodd 
et al., 2006).  
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Figure 4.8: Treatment removal efficiency for ciprofloxacin 
4.1.9 DEET 
DEET (N,N-Diethyl-meta-toluamide) is the most common ingredient in insect 
repellents. It can be applied to skin or clothing to repel mosquitoes. While the EPA maintains 
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that the chemical is safe when used correctly, DEET has been shown to cause nervous-
system damage. 
The removal efficiency of different treatment techniques for DEET is summarized in 
Figure 4.9 (expressed as % removal). Similar to previous studies (Ternes et al., 2002; 
Westerhoff et al., 2005; Stackelberg et al., 2007; Snyder et al., 2007), DEET was consistently 
resistant to conventional treatments in the lab-scale stimulation while GAC filtration was 
able to remove 30% to 90% of DEET. However, when a higher ozone dosage was applied, 
higher removal of DEET was achieved (Snyder et al., 2007; Westerhoof et al., 2005). 
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Figure 4.9: Treatment removal efficiency for DEET 
4.1.10 TCEP 
TCEP (tris(2-carboxyethyl)phosphine) is a reducing agent (flame retardant) 
frequently used in biochemistry and molecular biology applications (Ruegg et al., 1977). It is 
soluble in water and available as a stabilized solution at neutral pH and immobilized onto an 
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agarose support to facilitate removal of the reducing agent. In repeat dose experiment, TCEP 
causes adverse effects on the brain, liver and kidneys. However, Data indicating low 
environmental exposures support the conclusion that TCEP poses a very low risk of adverse 
health effects for the general population (WHO, 1999).   
The treatment removal efficiency for TCEP is summarized in Figure 4.10 and it is 
expressed as % removal. Similar to other studies in drinking water treatment (Snyder et al., 
2007; Westerhoof et al., 2005), TCEP showed a strong resistance to all of the treatment 
techniques, less than 20% of TCEP was removed during the treatment process. 
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Figure 4.10: Treatment removal efficiency for TCEP 
 
4.2 Conclusions 
From the results, several conclusions can be drawn: 
1. Coagulation doesn’t achieve significant removal for most of the target 
compounds.  
171 
 
2. Oxidation processes such as chlorination, chloramination and ozonation are 
capable of removing most of the target compounds except DEET and TCEP 
which are resistant to most of the treatment techniques.  
3. Filtration through GAC is effective for the removal of DEET which could be 
attributable to adsorption.  
4. Ozone-GAC biofiltration treatment is very effective for control of EDCs and 
PPCPs and produces less oxidation byproducts (could be removed through 
GAC filtration and adsorption) compared to the oxidation-alone processes. 
4.3 Recommendations for future work 
1. The bench-scale water treatment simulation indicated that the oxidation 
processes were very effective in removing of most of the target compounds. However, 
while removing the target compounds, oxidation produces oxidation byproducts that 
might have negative effects on human health and may be difficult to be removed by 
treatment following oxidation. As a result, conducting oxidation study to compare the 
ability of different oxidants for removing the target compounds and analyzing the 
oxidation byproducts will help the participating utilities in choosing oxidants for various 
raw waters. According to the results in Chapter 3, chlorine, chlorine dioxide, chloramine 
and ozone should be chosen for this oxidation study. The doses should be selected in 
consultation with the utilities. 
2. As illustrated by this project and in other pervious work, the combination of 
ozone and biofiltration (e.g. GAC) is well recognized as being highly effective in 
removing trace organic contaminants in water.  Another recommendation for future 
research could be establishing guidelines for the use of ozone-GAC for control of EDCs 
and related compounds in water. A ozone-GAC pilot will be set up in a constant 
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temperature room for this study. The same spike solution used in the project should be 
injected to the raw water of the pilot. Various filter flow rates, ozone doses and 
temperatures will be studies in order to define their effects on the performance of the 
ozone-GAC system. In addition, the removal efficiency for oxidation byproducts by GAC 
will also be studied. 
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